0001410578-22-002627.txt : 20220815 0001410578-22-002627.hdr.sgml : 20220815 20220815174646 ACCESSION NUMBER: 0001410578-22-002627 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Consumer Acquisition Corp CENTRAL INDEX KEY: 0001846288 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS MANUFACTURING INDUSTRIES [3990] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40468 FILM NUMBER: 221167118 BUSINESS ADDRESS: STREET 1: 1926 RAND RIDGE COURT CITY: MARIETTA STATE: NY ZIP: 30062 BUSINESS PHONE: 7706565712 MAIL ADDRESS: STREET 1: 1926 RAND RIDGE COURT CITY: MARIETTA STATE: NY ZIP: 30062 10-Q 1 gacqu-20220630x10q.htm 10-Q
50193635019363318263000179306321826300018822210.010.020.080.085019363210717501936345045780.010.020.080.08000001846288--12-312022Q2false30.50.5P5Y18263000179306321826300018822210.010.020.080.085019363210717501936345045780.010.020.080.0800501936350193634565750http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares50193630001846288gacqu:CommonStockSubjectToRedemptionMember2022-06-300001846288gacqu:CommonStockSubjectToRedemptionMember2021-12-310001846288gacqu:CommonClassaSubjectToRedemptionMember2022-06-300001846288gacqu:CommonClassaSubjectToRedemptionMember2021-12-310001846288us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001846288gacqu:FounderSharesMembergacqu:SponsorMember2021-01-152021-01-150001846288us-gaap:CommonStockMember2021-01-012021-03-310001846288us-gaap:RetainedEarningsMember2022-06-300001846288us-gaap:RetainedEarningsMember2022-03-310001846288us-gaap:RetainedEarningsMember2021-12-310001846288us-gaap:RetainedEarningsMember2021-06-300001846288us-gaap:RetainedEarningsMember2021-03-310001846288us-gaap:AdditionalPaidInCapitalMember2021-03-3100018462882021-03-310001846288us-gaap:RetainedEarningsMember2020-12-310001846288gacqu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001846288gacqu:PublicWarrantsMember2022-03-310001846288gacqu:PrivatePlacementWarrantsMember2022-03-3100018462882022-03-310001846288gacqu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001846288gacqu:PublicWarrantsMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMember2021-12-310001846288gacqu:PublicWarrantsMember2021-09-300001846288gacqu:PrivatePlacementWarrantsMember2021-09-3000018462882021-09-300001846288gacqu:PublicWarrantsMember2021-06-300001846288gacqu:PrivatePlacementWarrantsMember2021-06-300001846288gacqu:PublicWarrantsMember2021-06-100001846288gacqu:PrivatePlacementWarrantsMember2021-06-1000018462882021-06-100001846288us-gaap:PrivatePlacementMember2021-06-160001846288us-gaap:OverAllotmentOptionMember2021-06-160001846288gacqu:PrivatePlacementUnitsMemberus-gaap:PrivatePlacementMember2021-06-110001846288gacqu:PrivatePlacementUnitsMemberus-gaap:OverAllotmentOptionMember2021-06-110001846288us-gaap:IPOMember2021-06-110001846288us-gaap:CommonStockMember2022-03-310001846288us-gaap:CommonStockMember2021-12-310001846288us-gaap:CommonStockMember2021-06-300001846288us-gaap:CommonStockMember2021-03-3100018462882022-06-302022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-06-162021-06-160001846288gacqu:PromissoryNoteWithRelatedPartyMembergacqu:SponsorMember2022-06-300001846288gacqu:PromissoryNoteWithRelatedPartyMembergacqu:SponsorMember2021-12-310001846288us-gaap:RetainedEarningsMember2021-01-012021-03-3100018462882021-01-012021-03-310001846288gacqu:PublicWarrantsMember2022-04-012022-06-300001846288gacqu:PrivatePlacementWarrantsMember2022-04-012022-06-300001846288gacqu:PublicWarrantsMember2022-01-012022-03-310001846288gacqu:PrivatePlacementWarrantsMember2022-01-012022-03-310001846288gacqu:PublicWarrantsMember2021-10-012021-12-310001846288gacqu:PrivatePlacementWarrantsMember2021-10-012021-12-3100018462882021-10-012021-12-310001846288gacqu:PublicWarrantsMember2021-07-012021-09-300001846288gacqu:PrivatePlacementWarrantsMember2021-07-012021-09-3000018462882021-07-012021-09-300001846288gacqu:PublicWarrantsMember2021-06-112021-06-300001846288gacqu:PrivatePlacementWarrantsMember2021-06-112021-06-3000018462882021-06-112021-06-300001846288gacqu:CommonStockSubjectToRedemptionMember2022-04-012022-06-300001846288gacqu:CommonStockNotSubjectToRedemptionMember2022-04-012022-06-300001846288gacqu:CommonStockSubjectToRedemptionMember2022-01-012022-06-300001846288gacqu:CommonStockNotSubjectToRedemptionMember2022-01-012022-06-300001846288gacqu:CommonStockSubjectToRedemptionMember2021-04-012021-06-300001846288gacqu:CommonStockNotSubjectToRedemptionMember2021-04-012021-06-300001846288gacqu:CommonStockSubjectToRedemptionMember2021-01-012021-06-300001846288gacqu:CommonStockNotSubjectToRedemptionMember2021-01-012021-06-300001846288gacqu:AdministrativeSupportAgreementMember2022-06-300001846288gacqu:AdministrativeSupportAgreementMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:ProbabilityOfAcquisitionMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:MeasurementInputStockPriceMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:ProbabilityOfAcquisitionMember2021-12-310001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:MeasurementInputStockPriceMember2021-12-310001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:ProbabilityOfAcquisitionMember2021-06-110001846288gacqu:PublicAndPrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membergacqu:MeasurementInputStockPriceMember2021-06-110001846288us-gaap:WarrantMember2022-06-300001846288gacqu:ExtensionLoanMember2022-06-090001846288gacqu:FounderSharesMember2022-06-300001846288us-gaap:CommonStockMember2022-06-300001846288gacqu:PublicWarrantsMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMember2022-06-300001846288us-gaap:IPOMember2021-06-080001846288gacqu:PublicWarrantsMemberus-gaap:IPOMember2022-06-0800018462882021-06-3000018462882020-12-310001846288us-gaap:IPOMember2022-06-300001846288us-gaap:USTreasurySecuritiesMember2022-06-300001846288us-gaap:USTreasurySecuritiesMember2021-12-310001846288us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001846288us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001846288us-gaap:PrivatePlacementMember2021-06-162021-06-160001846288us-gaap:OverAllotmentOptionMember2021-06-162021-06-160001846288gacqu:PrivatePlacementUnitsMemberus-gaap:PrivatePlacementMember2021-06-112021-06-110001846288gacqu:PrivatePlacementUnitsMemberus-gaap:OverAllotmentOptionMember2021-06-112021-06-110001846288us-gaap:OverAllotmentOptionMember2021-06-112021-06-110001846288us-gaap:IPOMember2021-06-112021-06-110001846288us-gaap:CommonStockMember2021-04-012021-06-300001846288srt:MinimumMember2022-01-012022-06-300001846288srt:MaximumMember2022-01-012022-06-3000018462882021-01-012021-12-310001846288gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Membergacqu:PublicWarrantsMember2022-06-300001846288gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Membergacqu:PublicWarrantsMember2022-06-300001846288gacqu:AdministrativeSupportAgreementMember2022-01-012022-06-300001846288gacqu:ExtensionLoanMember2022-06-062022-06-060001846288gacqu:FounderSharesMembergacqu:SponsorMember2021-06-082021-06-080001846288us-gaap:IPOMember2021-06-162021-06-160001846288gacqu:PublicWarrantsMemberus-gaap:IPOMember2021-06-082021-06-080001846288gacqu:FounderSharesMember2021-06-160001846288us-gaap:IPOMember2021-06-082021-06-0800018462882021-01-040001846288gacqu:ExtensionLoanMember2022-01-012022-06-3000018462882022-01-220001846288gacqu:PromissoryNoteWithRelatedPartyMember2021-01-310001846288gacqu:RelatedPartyLoansMember2022-01-222022-01-220001846288gacqu:RelatedPartyLoansMember2022-06-300001846288gacqu:ExtensionLoanMember2022-06-3000018462882022-06-062022-06-0600018462882021-12-310001846288us-gaap:IPOMember2021-06-1600018462882022-06-300001846288gacqu:WorkingCapitalLoansMembergacqu:RelatedPartyLoansMember2022-06-300001846288gacqu:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-06-160001846288gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Membergacqu:PublicWarrantsMember2022-01-012022-06-300001846288gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Membergacqu:PublicWarrantsMember2022-01-012022-06-300001846288gacqu:PublicWarrantsMember2022-01-012022-06-300001846288gacqu:FounderSharesMembergacqu:SponsorMember2021-06-080001846288us-gaap:RetainedEarningsMember2022-04-012022-06-3000018462882022-04-012022-06-300001846288us-gaap:RetainedEarningsMember2022-01-012022-03-3100018462882022-01-012022-03-310001846288us-gaap:RetainedEarningsMember2021-04-012021-06-300001846288us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-3000018462882021-04-012021-06-3000018462882021-01-012021-06-300001846288us-gaap:CommonStockMember2022-01-012022-06-300001846288gacqu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember2022-01-012022-06-300001846288gacqu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember2022-01-012022-06-3000018462882022-08-1500018462882022-01-012022-06-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesgacqu:Dgacqu:Votegacqu:itemxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

Commission File No. 001-40468

GLOBAL CONSUMER ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Delaware

    

86-1229973

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.) 

1926 Rand Ridge Court

Marietta GA, 30062

(Address of Principal Executive Offices, including zip code)

(404) 939-9419

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

GACQ

 

The Nasdaq Stock Market LLC

Warrants

 

GACQW

 

The Nasdaq Stock Market LLC

Units

 

GACQU

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 

 Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes   No 

As of August 15, 2022, there were 23,282,362 shares of the Company’s common stock, $0.0001 par value per share, issued and outstanding, which includes shares of common stock underlying the units and warrants.

TABLE OF CONTENTS

Page

PART 1 – FINANCIAL INFORMATION

1

Item 1.

INTERIM FINANCIAL STATEMENTS (Unaudited)

1

Condensed Balance Sheets as of June 30, 2022 (unaudited) and December 31, 2021 (audited)

2

Condensed Statements of Operations for the Three Months Ended June 30, 2022 and 2021 (unaudited) and the Six Months Ended June 30, 2022 and 2021 (unaudited)

3

Condensed Statements of Changes in Shareholders’ Deficit for the Six Months Ended June 30, 2022 and 2021 (unaudited)

4

Condensed Statements of Cash Flows for the Six Months Ended June 30, 2022 and 2021 (unaudited)

5

Notes to Condensed Financial Statements

6

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

20

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

24

Item 4.

CONTROLS AND PROCEDURES

24

PART II – OTHER INFORMATION

26

Item 1.

LEGAL PROCEEDINGS

26

Item 1A.

RISK FACTORS

26

Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

26

Item 3.

DEFAULTS UPON SENIOR SECURITIES

26

Item 4.

MINE SAFETY DISCLOSURES

26

Item 5.

OTHER INFORMATION

26

Item 6.

EXHIBITS

27

SIGNATURES

28

i

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

1

Global Consumer Acquisition Corp.

Condensed Balance Sheets

    

June 30

    

December 31, 

2022

2021

(Unaudited)

(Audited)

ASSETS

Current Assets

Cash

$

83,302

$

257,271

Prepaid expense

29,750

80,169

Other receivable

 

75,000

 

Total Current Assets

188,052

337,440

 

 

Cash and Marketable Securities held in Trust Account

185,439,396

183,570,432

Total Assets

$

185,627,448

$

183,907,872

LIABILITIES AND STOCKHOLDERS’ DIFICIT

 

 

  

Current Liabilities

Due to related parties

$

40,000

$

Accrued expense

2,669,728

1,740,131

Franchise tax payable

53,879

113,648

Promissory notes

1,066,586

Extension note

1,826,300

Total Current Liabilities

5,656,493

1,853,779

Warrant Liability

 

1,864,265

 

5,773,748

Deferred underwriting fees

 

5,935,475

 

5,935,475

Total Liabilities

 

13,456,233

 

13,563,002

 

 

  

Commitments and Contingencies (NOTE 6)

 

 

  

Common stock subject to possible redemption, 18,263,000 shares, $0.0001 par value, at redemption value of $10.15 and $10.05 per share on June 30, 2022 and December 31, 2021, respectively

185,385,517

183,570,432

Stockholders’ Deficit

 

 

  

Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

 

 

Common stocks, $0.0001 par value; 100,000,000 shares authorized; 5,019,363 issued and outstanding (excluding 18,263,000 shares subject to possible redemption) at June 30, 2022 and December 31, 2021, respectively

 

502

 

502

Additional paid-in capital

 

 

Accumulated deficit

 

(13,214,804)

 

(13,226,064)

Total Stockholders’ Deficit

 

(13,214,302)

 

(13,225,562)

Total Liabilities and Stockholders’ Deficit

$

185,627,448

$

183,907,872

The accompanying notes are an integral part of the unaudited condensed financial statements.

2

Global Consumer Acquisition Corp.

Condensed Statements of Operations

For Three Month Ended June 30

For Six Months Ended June 30,

    

2022

    

2021

    

2022

    

2021

Unaudited

Unaudited

Unaudited

Unaudited

Formation and operating costs

$

902,313

$

104,676

$

2,044,656

$

150,306

Franchise tax

50,000

100,000

Loss from operation costs

(952,313)

(104,676)

(2,144,656)

(150,306)

Other income and expense:

Realized and unrealized gain from marketable securities held in Trust Account

$

132,004

$

2,025

$

88,104

$

2,025

Interest expense

(26,586)

(26,586)

Change in fair value of warrant liability

615,931

116,216

3,909,483

116,216

Non-operating expense

(450,846)

(450,846)

Net income (loss)

$

(230,964)

$

(437,281)

$

1,826,345

$

(482,911)

Weighted average shares outstanding of redeemable common stock

18,263,000

17,930,632

18,263,000

1,882,221

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Weighted average shares outstanding of non-redeemable common stock

5,019,363

210,717

5,019,363

4,504,578

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

The accompanying notes are an integral part of the unaudited condensed financial statements.

3

Global Consumer Acquisition Corp.

Condensed Statements of Changes in Stockholders’ Deficit

Three and Six Months Ended June 30, 2021 and 2022

Additional

Total

Common Stock

Paid-In

Accumulated

Stockholders’

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance — January 1, 2021 (audited)

$

$

$

(478)

$

(478)

Issuance of common stock to Sponsor

4,887,500

489

24,511

25,000

Net Loss

(45,630)

(45,630)

Balance — March 31, 2021 (unaudited)

4,887,500

$

489

$

24,511

$

(46,108)

$

(21,108)

Re-measurement for common stock to redemption amount

(4,321,343)

(14,311,924)

(18,633,267)

Forfeiture of founder shares

(321,750)

(32)

32

Sale of Private Units

453,613

45

4,296,800

4,296,845

Net Loss

(437,281)

(437,281)

Balance — June 30, 2021 (unaudited)

 

5,019,363

$

502

$

$

(14,795,313)

$

(14,794,811)

Additional

Total

Common Stock

Paid-In

Accumulated

Stockholders’

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance — January 1, 2022 (audited)

5,019,363

$

502

$

$

(13,226,064)

$

(13,225,562)

Net Income

2,057,309

2,057,309

Re-measurement for common stock to redemption amount

43,900

43,900

Balance — March 31, 2022 (unaudited)

5,019,363

$

502

$

$

(11,124,855)

$

(11,124,353)

Net Income

(230,964)

(230,964)

Additional amount deposited into trust ($0.10 per common stock subject to possible redemption)

(1,826,300)

(1,826,300)

Re-measurement for common stock to redemption amount

(32,685)

(32,685)

Balance — June 30, 2022 (unaudited)

5,019,363

$

502

$

$

(13,214,804)

(13,214,302)

The accompanying notes are an integral part of the unaudited condensed financial statements.

4

Global Consumer Acquisition Corp.

Condensed Statements of Cash Flows

For Six Months Ended June 30

2022

2021

    

(Unaudited)

    

(Unaudited)

Cash flows from operating activities:

Net income (loss)

$

1,826,345

$

(482,911)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Realized and unrealized gain from marketable securities held in Trust Account

(88,104)

(2,025)

Change in fair value of warrant liability

(3,909,483)

(116,215)

Offering costs allocated to warrants

450,846

Changes in operating assets and liabilities:

Prepaid expenses

50,419

(387,868)

Other Receivable

(75,000)

Due to related parties

40,000

Accrued expenses

929,597

80,787

Franchise tax payable

(59,769)

Promissory note-interest

26,586

Net cash used in operating activities

 

(1,259,409)

 

(457,386)

Cash flows from investing activities:

Investment of cash in Trust Account

 

(1,826,300)

 

(183,543,150)

Withdraw from Trust Account for Franchise tax payment

45,440

Net cash used in investing activities

(1,780,860)

(183,543,150)

Cash flows from financing activities:

Proceeds from promissory note

1,040,000

Proceeds from Extension notes

1,826,300

Proceeds from issue of founder shares

25,000

Proceeds from sale of units, net underwriting discount paid

 

 

180,347,335

Proceeds from sale of private placement

4,536,125

Payment of offering costs

 

 

(242,932)

Net cash provided by financing activities

 

2,866,300

 

184,665,528

Net change in cash

(173,969)

664,992

Cash at beginning of period

257,271

Cash at end of period

$

83,302

$

664,992

 

 

Non-cash investing and financing activities:

 

 

Initial classification of common stock subject to possible redemption

$

$

152,100,293

Re-measurement of common stock subject to redemption

$

1,815,085

$

11,648,045

Deferred underwriting fee payable

$

$

5,935,475

Offering costs charged to additional paid in capital

$

$

23,911

Offering costs charged to promissory note-related party

$

$

143,563

Initial classification of warrant liability

$

9,781,698

$

9,781,698

The accompanying notes are an integral part of the unaudited condensed financial statements.

5

Global Consumer Acquisition Corp.

Notes to Financial Statements

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

Global Consumer Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on December 28, 2020. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer products and services sectors.

For the three months ended June 30, 2022 the Company had not commenced any operations. All activity for the three months ended June 30, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s IPO was declared effective on June 8, 2021. On June 11, 2021, the Company consummated its IPO of 17,000,000 Units, at a price of $10.00 per unit, generating gross proceeds of $170,000,000, which is described in Note 4.

Simultaneously with the closing of the IPO, pursuant to a certain private placement unit subscription agreement, the Company completed the private sale of 431,510 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $4,315,100. In connection with the closing of the purchase of the Over-Allotment Units, the Company sold an additional 22,103 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating an additional $221,025 of gross proceeds. The sales of private placement units generated proceeds with an aggregate amount of $4,536,130 to the Company, which is described in Note 4.

Following the closing of the IPO on June 11, 2021 and the partially exercised over-allotment of 18,263,000 Units by the underwriter on June 16, 2021, an amount of $182,630,000 ($10.00 per unit) from the net proceeds of the sale of the Public Units in the IPO and the sale of the Private Placement Units of 453,613 units to the Sponsor at a purchase price of $10.00 per unit, generating gross proceeds to the Company of $4,536,130, which was placed in a trust account (the “Trust Account”), and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below, except that interest earned on the Trust Account can be released to the Company to pay its tax obligations (“permitted withdrawals”).

Transaction costs amounted to $8,628,545, consisting of $2,282,875 of underwriting fees, $5,935,475 deferred underwriting fee and $410,195 of other offering costs. In addition, as of June 30 2022, $83,302 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned and less any interest earned thereon that is released for taxes) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

6

As of June 30, 2022 and December 31, 2021, the Common Stock issued to the public reflected on the balance sheet are reconciled in the following table:

    

As of June 30, 2022

    

As of December 31, 2021

(Unaudited)

(Audited)

Gross Proceeds

$

182,630,000

$

182,630,000

Less:

 

 

Proceeds allocated to public warrants

 

(9,542,418)

 

(9,542,418)

Transaction costs

 

(8,628,545)

 

(8,628,545)

Plus:

 

 

Reverse the cost allocation to warrants

 

450,846

 

450,846

Additional amount deposited into trust

1,826,300

Re-measurement of carrying value to redemption value

 

18,649,334

 

18,690,549

Common stock subject to possible redemption

 

185,385,517

 

183,570,432

The Company will provide its Stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.

If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.

The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Common Stock will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

The Sponsor has agreed (a) to vote its Common Stock, the Common Stock included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the IPO in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Common Stock) and Private Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Common Stock and Private Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the IPO if the Company fails to complete its Business Combination.

7

The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.00 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022.

Going Concern and Management’s Plan

As of June 30, 2022, the Company had $83,302 in cash held in its operating account and working capital deficit of $5,468,441.

The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination. In addition, the Company expects to have negative cash flows from operations as it pursues an initial business combination target. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company does not currently have adequate liquidity to sustain operations, which consist solely of pursuing a Business Combination.

While the Company expects to have sufficient access to additional sources of capital if necessary, the Sponsor has signed a new Promissory Note with the Company to provide additional capital. On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. On June 30, 2022, the Company has drawn $1,040,000 from the Promissory Note. However, no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

8

As is customary for a special purpose acquisition company, if the Company is not able to consummate a Business Combination during the Combination Period, it will cease all operations and redeem the Public Shares. Management plans to continue its efforts to consummate a Business Combination during the Combination Period.

Risks and Uncertainties

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and the World. As of the date the financial statement was issued, there was considerable uncertainty around the expected duration of this pandemic. The Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 25, 2022. The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements included in the aforementioned Form 10-K. The interim results for the six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

9

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $83,302 and $257,271 cash held in its operating account and no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Derivative financial instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.

Warrant Liabilities

The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Public warrants had detached from the units and were trading publicly. As such, the Company utilized the public trading price for its fair value. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

10

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.

Net Income (Loss) per Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income (loss) per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 9,538,306 shares of common stock in the aggregate.

The following table reflects the calculation of basic and diluted net income per common stock:

For the three months ended

For the six months ended

June 30

June 30

    

2022

    

2021

    

2022

    

2021

Redeemable common stock

Numerator:

 

 

 

 

Net income (loss) allocable to common stock subject to possible redemption

$

(181,170)

$

(432,202)

$

1,432,611

$

(142,316)

Denominator: weighted average number of common stock

18,263,000

17,930,632

18,263,000

1,882,221

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Non-redeemable common stock

Numerator:

Net income (loss) allocable to common stock subject to possible redemption

$

(49,793)

$

(5,079)

$

393,735

$

(340,595)

Denominator: weighted average number of common stock

5,019,363

210,717

5,019,363

4,504,578

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

11

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for June 30, 2022, and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before provision for income taxes due principally to non-taxable items and the valuation allowance recorded on the Company’s deferred tax assets.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards update, if currently adopted, would have a material effect on the Company’s financial statements.

12

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the IPO on June 8, 2021, the Company sold 18,263,000 Units, which includes the partial exercise by the underwriter of its over-allotment option on June 16, 2021, in the amount of 1,263,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one common stock and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one-half of one common stock at an exercise price of $11.50 per whole share (see Note 7).

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the IPO on June 11, 2021, and the partial exercise by the underwriter of its over-allotment option on June 16, 2021, the initial stockholders purchased an aggregate of 453,613 Placement Units at a price of $10.00 per Placement Unit, ($4,536,125 in the aggregate), from the Company in a private placement that occurred simultaneously with the closing of the IPO and the full exercise by the underwriter of its over-allotment option. The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account. The Placement Units are identical to the Units sold in the IPO, except for the placement warrants (“Placement Warrants”), as described in Note 7.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On January 15, 2021, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in exchange for 5,750,000 founder shares. On June 8, 2021, the Sponsor surrendered an aggregate of 862,500 shares of common stock for no consideration, resulting in an aggregate of 4,887,500 founder shares of common stock issued and outstanding. Such common stock includes an aggregate of up to 637,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the initial stockholders do not purchase any Public Shares in the Initial Public Offering and excluding the Placement Units and underlying securities). Due to the over-allotment option was partially exercised by the Underwriter on June 16, 2021, the Sponsor has agreed to return 321,750 founder shares to the Company for cancellation. The cancellation agreement has been signed on June 16, 2021, yet Continental Stock Transfer & Trust Company has not processed the cancellation on their account due to processing reasons. As of June 30, 2022, there are 4,565,750 founder shares of common stock issued and outstanding.

The initial stockholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property.

Promissory Note – Related Party

On January 31, 2021, the Sponsor issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000, to be used for payment of costs related to the Initial Public Offering. The note is non-interest bearing and payable on the earlier of (i) July 31, 2021 or (ii) the consummation of the Initial Public Offering. The Promissory Note was repaid to Sponsor in full on July 20, 2021. As of June 30, 2022 and December 31, 2021, no amounts were outstanding.

Administrative Services Arrangement

ARC Group Limited, our financial advisor, has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay $10,000 per month for these services. For the June 30, 2022 and December 31, 2021, the due to related party in connection with administrative service amounted $40,000 and zero, respectively.

13

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. The unpaid principal amount outstanding will bear simple interest at the rate of 8% per annum. As of June 30, 2022, $1,066,586 were outstanding, of which $26,586 was interest expense accrued and payable balance.

Extension Loan

The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022. On June 9, 2022, the Company issued unsecured promissory note in the aggregate principal amount of $1,826,300 to the Sponsor, in exchange for Sponsor depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination. As of June 30, 2022, $1,826,300 were outstanding and $1,826,300 were deposited into the Company’s trust account.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on January 4, 2021, the holders of the Founder Shares, Placement units, Representative Shares are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise its demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the IPO. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

14

Right of First Refusal

For a period beginning on June 8, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.

NOTE 7. WARRANT LIABILITY

As of June 30, 2022, the Company has 9,358,306 warrants issued in the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company’s statement of operations.

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the Company’s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company’s shares of common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

Redemption of warrants when the price per common stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per warrant;
upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the closing price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

15

Redemption of warrants when the price per common stock equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.10 per warrant;
upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the closing price of the Company’s common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company accounted for the 9,358,306 warrants issued in connection with the Initial Public Offering (comprised of 9,131,500 Public Warrants and 226,806 Private Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.

The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. At June 30, 2022 and December 31, 2021, the fair value of total warrant liability is $1,864,265 and $5,773,748, respectively. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

NOTE 8. STOCKHOLDER’S EQUITY (DEFICIT)

Common Stock — The Company was authorized to issue 10,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 5,019,363 shares of Common Stock issued and outstanding, excluding 18,263,000 shares of Common Stock subject to possible redemption.

16

Preferred Shares — The Company was authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of June 30, 2022 and December 31, 2021, there were no preferred shares issued or outstanding.

NOTE 9. FAIR VALUE MEASUREMENTS

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.

Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3 Inputs: Significant inputs into the valuation model are unobservable.

The following table presents information about the Company’s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of June 30 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

    

Quoted Prices in

    

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

    

(Level 3)

(Unaudited)

(Unaudited)

(Unaudited)

Asset:

Marketable securities held in Trust Account

 

$

185,439,396

 

$

$

Warrant Liabilities:

Public Warrants

$

1,734,985

$

$

Private Placement Warrants

$

$

$

129,280

Quoted Prices in

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

(Level 3)

    

(Audited)

    

(Audited)

    

(Audited)

Asset:

 

  

 

  

 

  

Marketable securities held in Trust Account

$

183,570,432

$

$

Warrant Liabilities:

 

  

 

  

 

  

Public Warrants

$

5,478,900

$

$

Private Placement Warrants

$

$

$

294,848

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.The Warrants are measured at fair value on a recurring basis.

As of June 30, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $185,439,396 and $183,570,432 in U.S. Treasury Securities.

The Company accounted for the aggregate 9,358,306 warrants issued in connection with the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.

17

The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

The Company utilizes a binomial Monte-Carlo simulation to estimate the fair value of the private placement warrants at each reporting period for its warrants that are not actively traded. Beginning on July 29, 2021, the Public Warrants began trading under the ticker GACQW. After this date, Public Warrant values per share were based on the observed trading price of the Public Warrants. Accordingly, as of September 30, 2021, the observable input qualifies the liability for treatment as a Level 1 liability. The Company recognized $1,864,265 for the derivative warrant liabilities on June 30, 2022.

The estimated fair value of certain derivative warrant liabilities is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:

    

    

December 31, 2021

    

June 30, 2022

June 11, 2021

(Audited)

(Unaudited)

(Public Warrants

and

Private Warrants)

    

Private Warrants

Private Warrants

Exercise price

$

11.50

$

11.50

$

11.50

Share price

$

10.00

$

9.91

$

10.09

Expected term (years)

5.0

5.12

 

5.20

Probability of Acquisition

75.0

%

90.0

%

70.0

%

Volatility

18.0

%

20.0

%

 

7.6

%

Risk-free rate

0.81

%

1.26

%

2.97

%

Dividend yield (per share)

0.00

%

0.00

%

0.00

%

The change in the fair value of the derivative warrant liabilities for the period from June 11, 2021 (Initial Public Offering) through June 30, 2022, is summarized as follows:

    

Private Warrant

    

Public Warrant

    

Warrant Liability

Fair value as of June 11, 2021 (Initial Public Offering)

$

227,622

$

8,882,500

$

9,110,122

Change in valuation inputs or other assumptions(1)

14,153

541,208

555,361

Fair value as of June 30, 2021

$

241,775

$

9,423,708

$

9,665,483

Change in valuation inputs or other assumptions(1)(2)

(127,919)

(5,151,903)

(5,259,822)

Fair value as of September 30, 2021

$

113,856

$

4,291,805

$

4,405,661

Change in valuation inputs or other assumptions(1)(2)

180,992

1,187,095

1,368,087

Fair value as of December 31, 2021

$

294,848

$

5,478,900

$

5,773,748

Change in valuation inputs or other assumptions(1)(2)

(97,527)

(3,196,025)

(3,293,552)

Fair value as of March 31, 2022 (unaudited)

$

197,321

$

2,282,875

$

2,480,196

Change in valuation inputs or other assumptions(1)(2)

(68,041)

(547,890)

(615,931)

Fair value as of June 30, 2022 (unaudited)

$

129,280

$

1,734,985

$

1,864,265

(1)Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations.

18

(2)Changes are due to the use of quoted prices in an active market (Level 1) and the use of unobservable inputs based on assessment of the assumptions (Level 3) for Public Warrants (after becoming actively traded) and Private Placement Warrants, respectively.

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

19

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Annual Report on Form 10-K.

Overview

We are a blank check company formed under the laws of the State of Delaware on December 28, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our business combination using cash from the proceeds of the initial public offering and the sale of the private placement units, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

Business Combinations

On December 13, 2021, the Company has entered into the following agreements to acquire two business combination target companies for the purpose of consummating its initial business combination. Both target companies are in the home décor and fragrance products industry.

Luminex Home Décor & Fragrance Holding Corporation

On December 13, 2021, we entered into a Stock Purchase Agreement (the “Luminex SPA”) with CLP Luminex Holdings, LLC, a Delaware limited liability company (“Luminex Seller”), and Luminex Home Décor & Fragrance Holding Corporation, a Delaware corporation (“Luminex”). Pursuant to the terms of the Luminex SPA, a business combination between Global Consumer and Luminex will be effected by the acquisition of 100% of the issued and outstanding shares of capital stock of Luminex from Luminex Seller (the “Luminex Stock Acquisition”). The purchase price payable by Global Consumer to Luminex Seller in the Luminex Stock Acquisition is in the form of cash and is based on an enterprise value of 8 times LTM EBITDA of Luminex and its subsidiaries for the trailing twelve months ending January 31, 2022 (subject to an enterprise value floor of $160 million and a cap of $200 million). The purchase price is subject to adjustments and will be determined in good faith by Luminex and will be reviewed and approved prior to the Closing by an accounting firm.

The foregoing description of the Luminex SPA does not purport to be complete and is qualified in its entirety by the terms and conditions of the Luminex SPA, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on December 13, 2022.

GP Global Limited

On December 13, 2021, Global Consumer entered into a Stock Purchase Agreement (the “GP Global SPA”) by and among Global Consumer, TGP Trading FZCO, a freezone company with limited liability organized in Dubai Airport Free Zone, Dubai, United Arab Emirates (“GP Global Seller”), and GP Global Limited, an offshore company with limited liability organized in Jebel Ali Free Zone, Dubai, United Arab Emirates (“GP Global”). Mr. Gautham Pai, Co-Chairman of the board of GACQ and a member of the Sponsor owns 100% of the GP Global SPA. Pursuant to the terms of the GP Global SPA, a business combination between Global Consumer and GP Global will be effected by the acquisition of 100% of the issued and outstanding capital shares of GP Global from GP Global Seller (the “GP Global Stock Acquisition”). The purchase price payable by Global Consumer to GP Global Seller at the Closing of the GP Global Stock Acquisition is in the form of the issuance of shares of common stock of Global Consumer (the “Acquisition Consideration Shares”) (valued at $10 per share) and is based on an enterprise value of $270 Million. The purchase price is subject to adjustments and will be determined in good faith by GP Global and will be reviewed and approved prior to the Closing by an accounting firm.

20

The foregoing description of the GP Global SPA does not purport to be complete and is qualified in its entirety by the terms and conditions of the GP Global SPA, a copy of which was filed as Exhibit 2.2 to the Current Report on Form 8-K filed with the SEC on December 13, 2022.

Amendments to the Stock Purchase Agreements

On June 24, 2022, the Company, Luminex Seller and Luminex entered into the First Amendment to Stock Purchase Agreement (the “Luminex SPA Amendment”) to, among other things, extend the Outside Closing Date (as defined in the Luminex SPA) to August 15, 2022. With the exception of such amended terms, the Luminex SPA remains in full force and effect.

The foregoing description of the Luminex SPA Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions of the Luminex SPA Amendment, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on June 29, 2022 and incorporated by reference herein.

On June 24, 2022, the Company, GP Global Seller and GP Global entered into the First Amendment to Stock Purchase Agreement (the “GP Global SPA Amendment”) to extend the Outside Closing Date (as defined in the GP Global SPA) to September 11, 2022. With the exception of such amended terms, the GP Global SPA remains in full force and effect.

The foregoing description of the GP Global SPA Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions of the GP Global SPA Amendment, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on June 29, 2022 and incorporated by reference herein.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities for the three months ended June 30, 2022, were organizational activities and those necessary to prepare for the initial public offering, described below. We do not expect to generate any operating revenues until after the completion of our business combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the initial public offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2022, we had a net loss of $230,964, which consists of operating costs of $952,313, realized and unrealized loss from marketable securities held in the Trust Account of $132,004, interest expense of $26,586, and offset by change in fair value of warrant liability of $615,931.

For the three months ended June 30, 2021, we had a net loss of $437,281, which consists of operating costs of $104,676, non-operating costs $450,846, and offset by interest income on marketable securities held in the Trust Account of $2,025 and change in fair value of warrant liability of $116,216.

For the six months ended June 30, 2022, we had a net income of $1,826,345, which consists of operating costs of $2,144,656, realized and unrealized loss from marketable securities held in the Trust Account of $88,104, interest expense of $26,586, and offset by change in fair value of warrant liability of $3,909,483.

For the six months ended June 30, 2021, we had a net loss of $482,911, which consists of operating costs of $150,306, non-operating costs $450,846, and offset by interest income on marketable securities held in the Trust Account of $2,025 and change in fair value of warrant liability of $116,216.

Going Concern

As of June 30, 2022, we had cash and marketable securities of $185,439,396 held in the Trust Account. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable and excluding deferred underwriting commissions) to complete our initial Business Combination. To the extent that our common stocks or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

21

As of June 30, 2022, we had cash of $83,302 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that a business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would be identical to the private placement units.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant number of our public subunits upon consummation of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

The Company intends to complete the proposed Business Combination before September 8, 2022, and we believe we have sufficient arrangements with our vendors to continue to operate until we complete our initial Business Combination. However, there can be no assurance that the Company will be able to consummate the Business Combination by then. In the event that we are unable to consummate the Business Combination before September 8, 2022 we anticipate identifying and accessing additional capital resources in order to extend the Business Combination period up to 18 months. However, there can be no assurance that the Company will have access to sufficient capital to extend the deadline to consummate the Business Combination. As a result, in connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” it is uncertain that the Company will have sufficient liquidity to fund the working capital needs. Management has determined that the Company’s cash flow deficit raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited condensed financial statements are issued . No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of June 30, 2022.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than described below.

The underwriters are entitled to a deferred fee of $0.325 per unit, or $5,935,475 in the aggregate. The deferred fee will become payable to the underwriters solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement.

22

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the period reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 ”Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.

The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Common Stocks Subject to Possible Redemption

We account for our common stocks subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” common stocks subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stocks (including common stocks that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stocks are classified as stockholders’ equity (deficit). Our common stocks feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2021, 18,263,000 shares of common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of our interim balance sheets.

23

Net Income Per Common Stock

We apply the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 9,358,306 shares of common stock in the aggregate.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of June 30, 2022, we were not subject to any market or interest rate risk. The net proceeds held in the Trust Account have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less, or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including Mr. Rohan Ajila, our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, solely due to the Company’s lack of ability to account for complex financial instrument, the Company’s disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of June 30, 2022.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the evaluation of the SEC Statement and management’s subsequent re-evaluation of its Prior Financials, the Company determined that there were errors in its accounting for its warrants. Management concluded that a deficiency in internal control over financial reporting existed relating to the accounting treatment for complex financial instruments and that the failure to properly account for such instruments constituted a material weakness. This material weakness resulted in the need to restate the Prior Financials.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, with the exception of the below.

24

The Chief Executive Officer and Chief Financial Officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for Temporary Equity and the restatement of the Prior Financials. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation of the material weakness and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

25

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

ITEM 1A. RISK FACTORS

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our final prospectus for our Initial Public Offering filed with the SEC on June 10, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for our Initial Public Offering filed with the SEC on June 10, 2021.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of equity securities during the period covered by this Quarterly Report that were not registered under the Securities Act and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the company.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

26

ITEM 6. EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.

    

Description of Exhibit

2.1

First Amendment to Stock Purchase Agreement, dated as of June 24, 2022, by and among Global Consumer Acquisition Corp., CLP Luminex Holdings, LLC and Luminex Home Décor & Fragrance Holding Corporation (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on June 29, 2022)

2.2

First Amendment to Stock Purchase Agreement, dated as of June 24, 2022, by and among Global Consumer Acquisition Corp., TGP Trading FZCO and GP Global Limited (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on June 29, 2022)

31.1*

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

 

XBRL Instance Document

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*

 

XBRL Taxonomy Extension Schema Document

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document

*  Filed herewith.

**Furnished.

27

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Global Consumer Acquisition Corp.

 

 

 

Date: August 15, 2022

By:

/s/ Rohan Ajila

 

Name:

Rohan Ajila

 

Title:

Chief Executive Officer and Chief Financial Officer

 

 

(Principal Executive Officer, Principal Financial and Accounting Officer)

28

EX-31.1 2 gacqu-20220630xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rohan Ajila, certify that:

1

I have reviewed this quarterly report on Form 10-Q of Global Consumer Acquisition Corp.;

2

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022

    

/s/ Rohan Ajila

Rohan Ajila

Chief Executive Officer

(Principal Executive Officer)


EX-31.2 3 gacqu-20220630xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rohan Ajila, certify that:

1

I have reviewed this quarterly report on Form 10-Q of Global Consumer Acquisition Corp.;

2

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022

/s/ Rohan Ajila

Rohan Ajila

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-32.1 4 gacqu-20220630xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Global Consumer Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Rohan Ajila, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 15, 2022

/s/ Rohan Ajila

Rohan Ajila

Chief Executive Officer

(Principal Executive Officer)


EX-32.2 5 gacqu-20220630xex32d2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Global Consumer Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Rohan Ajila, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 15, 2022

/s/ Rohan Ajila

Rohan Ajila

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-101.SCH 6 gacqu-20220630.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Statements of Changes in Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - INITIAL PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - RELATED PARTY TRANSACTIONS - Extension loan (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - WARRANT LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - WARRANT LIABILITY link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30103 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 gacqu-20220630_cal.xml EX-101.CAL EX-101.DEF 8 gacqu-20220630_def.xml EX-101.DEF EX-101.LAB 9 gacqu-20220630_lab.xml EX-101.LAB EX-101.PRE 10 gacqu-20220630_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 15, 2022
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2022  
Entity File Number 001-40468  
Entity Registrant Name GLOBAL CONSUMER ACQUISITION CORP.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 86-1229973  
Entity Address, Address Line One 1926 Rand Ridge Court  
Entity Address, City or Town Marietta  
Entity Address State Or Province GA  
Entity Address, Postal Zip Code 30062  
City Area Code 404  
Local Phone Number 939-9419  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   23,282,362
Entity Central Index Key 0001846288  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Common Stock  
Trading Symbol GACQ  
Security Exchange Name NASDAQ  
Units    
Document Information [Line Items]    
Title of 12(b) Security Units  
Trading Symbol GACQU  
Security Exchange Name NASDAQ  
Warrants    
Document Information [Line Items]    
Title of 12(b) Security Warrants  
Trading Symbol GACQW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash $ 83,302 $ 257,271
Prepaid expense 29,750 80,169
Other receivable 75,000  
Total Current Assets 188,052 337,440
Cash and Marketable Securities held in Trust Account 185,439,396 183,570,432
Total Assets 185,627,448 183,907,872
Current Liabilities    
Due to related parties 40,000  
Accrued expense 2,669,728 1,740,131
Franchise tax payable 53,879 113,648
Promissory notes 1,066,586  
Extension note 1,826,300  
Total Current Liabilities 5,656,493 1,853,779
Warrant Liability 1,864,265 5,773,748
Deferred underwriting fees 5,935,475 5,935,475
Total Liabilities 13,456,233 13,563,002
Commitments and Contingencies (NOTE 6)
Common stock subject to possible redemption, 18,263,000 shares, $0.0001 par value, at redemption value of $10.15 and $10.05 per share on June 30, 2022 and December 31, 2021, respectively 185,385,517 183,570,432
Stockholders' Deficit    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stocks, $0.0001 par value; 100,000,000 shares authorized; 5,019,363 issued and outstanding (excluding 18,263,000 shares subject to possible redemption) at June 30, 2022 and December 31, 2021, respectively 502 502
Accumulated deficit (13,214,804) (13,226,064)
Total Stockholders' Deficit (13,214,302) (13,225,562)
Total Liabilities and Stockholders' Deficit 185,627,448 183,907,872
Class A Common Stock Subject to Redemption    
Current Liabilities    
Common stock subject to possible redemption, 18,263,000 shares, $0.0001 par value, at redemption value of $10.15 and $10.05 per share on June 30, 2022 and December 31, 2021, respectively $ 185,385,517 $ 183,570,432
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common shares, par value, (per share) $ 0.0001 $ 0.0001
Common shares, shares authorized 100,000,000 100,000,000
Common shares, shares issued 5,019,363 5,019,363
Common shares, shares outstanding 5,019,363 5,019,363
Common stock subject to redemption    
Temporary equity, shares outstanding 18,263,000 18,263,000
Redemption value per share $ 10.15 $ 10.05
Redemption par value $ 0.0001 $ 0.0001
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Formation and operating costs $ 902,313 $ 104,676 $ 2,044,656 $ 150,306
Franchise tax 50,000   100,000  
Loss from operation costs (952,313) (104,676) (2,144,656) (150,306)
Other income and expense:        
Realized and unrealized gain from marketable securities held in Trust Account 132,004 2,025 88,104 2,025
Interest expense (26,586)   (26,586)  
Change in fair value of warrant liability 615,931 116,216 3,909,483 116,216
Non-operating expense   (450,846)   (450,846)
Net income (loss) $ (230,964) $ (437,281) $ 1,826,345 $ (482,911)
Common stock subject to redemption        
Other income and expense:        
Weighted average shares outstanding, basic 18,263,000 17,930,632 18,263,000 1,882,221
Weighted average shares outstanding, diluted 18,263,000 17,930,632 18,263,000 1,882,221
Basic net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Diluted net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Non-redeemable common stock        
Other income and expense:        
Weighted average shares outstanding, basic 5,019,363 210,717 5,019,363 4,504,578
Weighted average shares outstanding, diluted 5,019,363 210,717 5,019,363 4,504,578
Basic net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Diluted net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020     $ (478) $ (478)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock to Sponsor $ 489 $ 24,511   25,000
Issuance of common stock to Sponsor (in shares) 4,887,500      
Net Income (Loss)     (45,630) (45,630)
Balance at the end at Mar. 31, 2021 $ 489 24,511 (46,108) (21,108)
Balance at the end (in shares) at Mar. 31, 2021 4,887,500      
Balance at the beginning at Dec. 31, 2020     (478) (478)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Re-measurement for common stock to redemption amount       (11,648,045)
Net Income (Loss)       (482,911)
Balance at the end at Jun. 30, 2021 $ 502   (14,795,313) (14,794,811)
Balance at the end (in shares) at Jun. 30, 2021 5,019,363      
Balance at the beginning at Mar. 31, 2021 $ 489 24,511 (46,108) (21,108)
Balance at the beginning (in shares) at Mar. 31, 2021 4,887,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Re-measurement for common stock to redemption amount   (4,321,343) (14,311,924) (18,633,267)
Forfeiture of founder shares $ (32) 32    
Forfeiture of founder shares (in shares) (321,750)      
Sale of Private Units $ 45 $ 4,296,800   4,296,845
Sale of Private Units (in shares) 453,613      
Net Income (Loss)     (437,281) (437,281)
Balance at the end at Jun. 30, 2021 $ 502   (14,795,313) (14,794,811)
Balance at the end (in shares) at Jun. 30, 2021 5,019,363      
Balance at the beginning at Dec. 31, 2021 $ 502   (13,226,064) (13,225,562)
Balance at the beginning (in shares) at Dec. 31, 2021 5,019,363      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Re-measurement for common stock to redemption amount     43,900 43,900
Net Income (Loss)     2,057,309 2,057,309
Balance at the end at Mar. 31, 2022 $ 502   (11,124,855) (11,124,353)
Balance at the end (in shares) at Mar. 31, 2022 5,019,363      
Balance at the beginning at Dec. 31, 2021 $ 502   (13,226,064) (13,225,562)
Balance at the beginning (in shares) at Dec. 31, 2021 5,019,363      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Re-measurement for common stock to redemption amount       (1,815,085)
Net Income (Loss)       1,826,345
Balance at the end at Jun. 30, 2022 $ 502   (13,214,804) (13,214,302)
Balance at the end (in shares) at Jun. 30, 2022 5,019,363      
Balance at the beginning at Mar. 31, 2022 $ 502   (11,124,855) (11,124,353)
Balance at the beginning (in shares) at Mar. 31, 2022 5,019,363      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Re-measurement for common stock to redemption amount     (32,685) (32,685)
Additional amount deposited into trust ($0.10 per common stock subject to possible redemption)     (1,826,300) (1,826,300)
Net Income (Loss)     (230,964) (230,964)
Balance at the end at Jun. 30, 2022 $ 502   $ (13,214,804) $ (13,214,302)
Balance at the end (in shares) at Jun. 30, 2022 5,019,363      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Changes in Stockholders' Deficit (Parenthetical) - $ / shares
3 Months Ended
Jun. 06, 2022
Jun. 30, 2022
Condensed Statements of Changes in Stockholders' Deficit    
Per share value of common stock subject to possible redemption deposited into trust $ 0.10 $ 0.10
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 1,826,345 $ (482,911)
Adjustments to reconcile net loss to net cash used in operating activities:    
Realized and unrealized gain from marketable securities held in Trust Account (88,104) (2,025)
Change in fair value of warrant liability (3,909,483) (116,215)
Offering costs allocated to warrants   450,846
Changes in operating assets and liabilities:    
Prepaid expenses 50,419 (387,868)
Other Receivable (75,000)  
Due to related parties 40,000  
Accrued expenses 929,597 80,787
Franchise tax payable (59,769)  
Promissory note-interest 26,586  
Net cash used in operating activities (1,259,409) (457,386)
Cash flows from investing activities:    
Investment of cash in Trust Account (1,826,300) (183,543,150)
Withdraw from Trust Account for Franchise tax payment 45,440  
Net cash used in investing activities (1,780,860) (183,543,150)
Cash flows from financing activities:    
Proceeds from promissory note 1,040,000  
Proceeds from Extension notes 1,826,300  
Proceeds from issue of founder shares   25,000
Proceeds from sale of units, net underwriting discount paid   180,347,335
Proceeds from sale of private placement   4,536,125
Payment of offering costs   (242,932)
Net cash provided by financing activities 2,866,300 184,665,528
Net change in cash (173,969) 664,992
Cash at beginning of period 257,271 0
Cash at end of period 83,302 664,992
Non-cash investing and financing activities:    
Initial classification of common stock subject to possible redemption   152,100,293
Re-measurement of common stock subject to redemption 1,815,085 11,648,045
Deferred underwriting fee payable   5,935,475
Offering costs charged to additional paid in capital   23,911
Offering costs charged to promissory note-related party   143,563
Initial classification of warrant liability $ 9,781,698 $ 9,781,698
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
6 Months Ended
Jun. 30, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

Global Consumer Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on December 28, 2020. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer products and services sectors.

For the three months ended June 30, 2022 the Company had not commenced any operations. All activity for the three months ended June 30, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s IPO was declared effective on June 8, 2021. On June 11, 2021, the Company consummated its IPO of 17,000,000 Units, at a price of $10.00 per unit, generating gross proceeds of $170,000,000, which is described in Note 4.

Simultaneously with the closing of the IPO, pursuant to a certain private placement unit subscription agreement, the Company completed the private sale of 431,510 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $4,315,100. In connection with the closing of the purchase of the Over-Allotment Units, the Company sold an additional 22,103 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating an additional $221,025 of gross proceeds. The sales of private placement units generated proceeds with an aggregate amount of $4,536,130 to the Company, which is described in Note 4.

Following the closing of the IPO on June 11, 2021 and the partially exercised over-allotment of 18,263,000 Units by the underwriter on June 16, 2021, an amount of $182,630,000 ($10.00 per unit) from the net proceeds of the sale of the Public Units in the IPO and the sale of the Private Placement Units of 453,613 units to the Sponsor at a purchase price of $10.00 per unit, generating gross proceeds to the Company of $4,536,130, which was placed in a trust account (the “Trust Account”), and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below, except that interest earned on the Trust Account can be released to the Company to pay its tax obligations (“permitted withdrawals”).

Transaction costs amounted to $8,628,545, consisting of $2,282,875 of underwriting fees, $5,935,475 deferred underwriting fee and $410,195 of other offering costs. In addition, as of June 30 2022, $83,302 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned and less any interest earned thereon that is released for taxes) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

As of June 30, 2022 and December 31, 2021, the Common Stock issued to the public reflected on the balance sheet are reconciled in the following table:

    

As of June 30, 2022

    

As of December 31, 2021

(Unaudited)

(Audited)

Gross Proceeds

$

182,630,000

$

182,630,000

Less:

 

 

Proceeds allocated to public warrants

 

(9,542,418)

 

(9,542,418)

Transaction costs

 

(8,628,545)

 

(8,628,545)

Plus:

 

 

Reverse the cost allocation to warrants

 

450,846

 

450,846

Additional amount deposited into trust

1,826,300

Re-measurement of carrying value to redemption value

 

18,649,334

 

18,690,549

Common stock subject to possible redemption

 

185,385,517

 

183,570,432

The Company will provide its Stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.

If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.

The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Common Stock will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

The Sponsor has agreed (a) to vote its Common Stock, the Common Stock included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the IPO in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Common Stock) and Private Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Common Stock and Private Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the IPO if the Company fails to complete its Business Combination.

The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.00 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022.

Going Concern and Management’s Plan

As of June 30, 2022, the Company had $83,302 in cash held in its operating account and working capital deficit of $5,468,441.

The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination. In addition, the Company expects to have negative cash flows from operations as it pursues an initial business combination target. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company does not currently have adequate liquidity to sustain operations, which consist solely of pursuing a Business Combination.

While the Company expects to have sufficient access to additional sources of capital if necessary, the Sponsor has signed a new Promissory Note with the Company to provide additional capital. On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. On June 30, 2022, the Company has drawn $1,040,000 from the Promissory Note. However, no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

As is customary for a special purpose acquisition company, if the Company is not able to consummate a Business Combination during the Combination Period, it will cease all operations and redeem the Public Shares. Management plans to continue its efforts to consummate a Business Combination during the Combination Period.

Risks and Uncertainties

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and the World. As of the date the financial statement was issued, there was considerable uncertainty around the expected duration of this pandemic. The Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 25, 2022. The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements included in the aforementioned Form 10-K. The interim results for the six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $83,302 and $257,271 cash held in its operating account and no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Derivative financial instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.

Warrant Liabilities

The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Public warrants had detached from the units and were trading publicly. As such, the Company utilized the public trading price for its fair value. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.

Net Income (Loss) per Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income (loss) per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 9,538,306 shares of common stock in the aggregate.

The following table reflects the calculation of basic and diluted net income per common stock:

For the three months ended

For the six months ended

June 30

June 30

    

2022

    

2021

    

2022

    

2021

Redeemable common stock

Numerator:

 

 

 

 

Net income (loss) allocable to common stock subject to possible redemption

$

(181,170)

$

(432,202)

$

1,432,611

$

(142,316)

Denominator: weighted average number of common stock

18,263,000

17,930,632

18,263,000

1,882,221

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Non-redeemable common stock

Numerator:

Net income (loss) allocable to common stock subject to possible redemption

$

(49,793)

$

(5,079)

$

393,735

$

(340,595)

Denominator: weighted average number of common stock

5,019,363

210,717

5,019,363

4,504,578

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for June 30, 2022, and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before provision for income taxes due principally to non-taxable items and the valuation allowance recorded on the Company’s deferred tax assets.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards update, if currently adopted, would have a material effect on the Company’s financial statements.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
INITIAL PUBLIC OFFERING
6 Months Ended
Jun. 30, 2022
INITIAL PUBLIC OFFERING.  
INITIAL PUBLIC OFFERING

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the IPO on June 8, 2021, the Company sold 18,263,000 Units, which includes the partial exercise by the underwriter of its over-allotment option on June 16, 2021, in the amount of 1,263,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one common stock and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one-half of one common stock at an exercise price of $11.50 per whole share (see Note 7).

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
PRIVATE PLACEMENT
6 Months Ended
Jun. 30, 2022
PRIVATE PLACEMENT.  
PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the IPO on June 11, 2021, and the partial exercise by the underwriter of its over-allotment option on June 16, 2021, the initial stockholders purchased an aggregate of 453,613 Placement Units at a price of $10.00 per Placement Unit, ($4,536,125 in the aggregate), from the Company in a private placement that occurred simultaneously with the closing of the IPO and the full exercise by the underwriter of its over-allotment option. The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account. The Placement Units are identical to the Units sold in the IPO, except for the placement warrants (“Placement Warrants”), as described in Note 7.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2022
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On January 15, 2021, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in exchange for 5,750,000 founder shares. On June 8, 2021, the Sponsor surrendered an aggregate of 862,500 shares of common stock for no consideration, resulting in an aggregate of 4,887,500 founder shares of common stock issued and outstanding. Such common stock includes an aggregate of up to 637,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the initial stockholders do not purchase any Public Shares in the Initial Public Offering and excluding the Placement Units and underlying securities). Due to the over-allotment option was partially exercised by the Underwriter on June 16, 2021, the Sponsor has agreed to return 321,750 founder shares to the Company for cancellation. The cancellation agreement has been signed on June 16, 2021, yet Continental Stock Transfer & Trust Company has not processed the cancellation on their account due to processing reasons. As of June 30, 2022, there are 4,565,750 founder shares of common stock issued and outstanding.

The initial stockholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property.

Promissory Note – Related Party

On January 31, 2021, the Sponsor issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000, to be used for payment of costs related to the Initial Public Offering. The note is non-interest bearing and payable on the earlier of (i) July 31, 2021 or (ii) the consummation of the Initial Public Offering. The Promissory Note was repaid to Sponsor in full on July 20, 2021. As of June 30, 2022 and December 31, 2021, no amounts were outstanding.

Administrative Services Arrangement

ARC Group Limited, our financial advisor, has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay $10,000 per month for these services. For the June 30, 2022 and December 31, 2021, the due to related party in connection with administrative service amounted $40,000 and zero, respectively.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. The unpaid principal amount outstanding will bear simple interest at the rate of 8% per annum. As of June 30, 2022, $1,066,586 were outstanding, of which $26,586 was interest expense accrued and payable balance.

Extension Loan

The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022. On June 9, 2022, the Company issued unsecured promissory note in the aggregate principal amount of $1,826,300 to the Sponsor, in exchange for Sponsor depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination. As of June 30, 2022, $1,826,300 were outstanding and $1,826,300 were deposited into the Company’s trust account.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2022
COMMITMENTS AND CONTINGENCIES.  
COMMITMENTS AND CONTINGENCIES

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on January 4, 2021, the holders of the Founder Shares, Placement units, Representative Shares are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise its demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the IPO. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Right of First Refusal

For a period beginning on June 8, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANT LIABILITY
6 Months Ended
Jun. 30, 2022
WARRANT LIABILITY  
WARRANT LIABILITY

NOTE 7. WARRANT LIABILITY

As of June 30, 2022, the Company has 9,358,306 warrants issued in the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company’s statement of operations.

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the Company’s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company’s shares of common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

Redemption of warrants when the price per common stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per warrant;
upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the closing price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

Redemption of warrants when the price per common stock equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.10 per warrant;
upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the closing price of the Company’s common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company accounted for the 9,358,306 warrants issued in connection with the Initial Public Offering (comprised of 9,131,500 Public Warrants and 226,806 Private Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.

The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. At June 30, 2022 and December 31, 2021, the fair value of total warrant liability is $1,864,265 and $5,773,748, respectively. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (DEFICIT)
6 Months Ended
Jun. 30, 2022
STOCKHOLDERS' EQUITY (DEFICIT)  
STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 8. STOCKHOLDER’S EQUITY (DEFICIT)

Common Stock — The Company was authorized to issue 10,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 5,019,363 shares of Common Stock issued and outstanding, excluding 18,263,000 shares of Common Stock subject to possible redemption.

Preferred Shares — The Company was authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of June 30, 2022 and December 31, 2021, there were no preferred shares issued or outstanding.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2022
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 9. FAIR VALUE MEASUREMENTS

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.

Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3 Inputs: Significant inputs into the valuation model are unobservable.

The following table presents information about the Company’s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of June 30 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

    

Quoted Prices in

    

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

    

(Level 3)

(Unaudited)

(Unaudited)

(Unaudited)

Asset:

Marketable securities held in Trust Account

 

$

185,439,396

 

$

$

Warrant Liabilities:

Public Warrants

$

1,734,985

$

$

Private Placement Warrants

$

$

$

129,280

Quoted Prices in

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

(Level 3)

    

(Audited)

    

(Audited)

    

(Audited)

Asset:

 

  

 

  

 

  

Marketable securities held in Trust Account

$

183,570,432

$

$

Warrant Liabilities:

 

  

 

  

 

  

Public Warrants

$

5,478,900

$

$

Private Placement Warrants

$

$

$

294,848

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.The Warrants are measured at fair value on a recurring basis.

As of June 30, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $185,439,396 and $183,570,432 in U.S. Treasury Securities.

The Company accounted for the aggregate 9,358,306 warrants issued in connection with the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.

The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

The Company utilizes a binomial Monte-Carlo simulation to estimate the fair value of the private placement warrants at each reporting period for its warrants that are not actively traded. Beginning on July 29, 2021, the Public Warrants began trading under the ticker GACQW. After this date, Public Warrant values per share were based on the observed trading price of the Public Warrants. Accordingly, as of September 30, 2021, the observable input qualifies the liability for treatment as a Level 1 liability. The Company recognized $1,864,265 for the derivative warrant liabilities on June 30, 2022.

The estimated fair value of certain derivative warrant liabilities is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:

    

    

December 31, 2021

    

June 30, 2022

June 11, 2021

(Audited)

(Unaudited)

(Public Warrants

and

Private Warrants)

    

Private Warrants

Private Warrants

Exercise price

$

11.50

$

11.50

$

11.50

Share price

$

10.00

$

9.91

$

10.09

Expected term (years)

5.0

5.12

 

5.20

Probability of Acquisition

75.0

%

90.0

%

70.0

%

Volatility

18.0

%

20.0

%

 

7.6

%

Risk-free rate

0.81

%

1.26

%

2.97

%

Dividend yield (per share)

0.00

%

0.00

%

0.00

%

The change in the fair value of the derivative warrant liabilities for the period from June 11, 2021 (Initial Public Offering) through June 30, 2022, is summarized as follows:

    

Private Warrant

    

Public Warrant

    

Warrant Liability

Fair value as of June 11, 2021 (Initial Public Offering)

$

227,622

$

8,882,500

$

9,110,122

Change in valuation inputs or other assumptions(1)

14,153

541,208

555,361

Fair value as of June 30, 2021

$

241,775

$

9,423,708

$

9,665,483

Change in valuation inputs or other assumptions(1)(2)

(127,919)

(5,151,903)

(5,259,822)

Fair value as of September 30, 2021

$

113,856

$

4,291,805

$

4,405,661

Change in valuation inputs or other assumptions(1)(2)

180,992

1,187,095

1,368,087

Fair value as of December 31, 2021

$

294,848

$

5,478,900

$

5,773,748

Change in valuation inputs or other assumptions(1)(2)

(97,527)

(3,196,025)

(3,293,552)

Fair value as of March 31, 2022 (unaudited)

$

197,321

$

2,282,875

$

2,480,196

Change in valuation inputs or other assumptions(1)(2)

(68,041)

(547,890)

(615,931)

Fair value as of June 30, 2022 (unaudited)

$

129,280

$

1,734,985

$

1,864,265

(1)Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations.
(2)Changes are due to the use of quoted prices in an active market (Level 1) and the use of unobservable inputs based on assessment of the assumptions (Level 3) for Public Warrants (after becoming actively traded) and Private Placement Warrants, respectively.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2022
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 25, 2022. The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements included in the aforementioned Form 10-K. The interim results for the six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $83,302 and $257,271 cash held in its operating account and no cash equivalents as of June 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Derivative financial instruments

Derivative financial instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.

Warrant Liabilities

The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Public warrants had detached from the units and were trading publicly. As such, the Company utilized the public trading price for its fair value. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.

Net Income (Loss) per Common Stock

Net Income (Loss) per Common Stock

The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income (loss) per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for 9,538,306 shares of common stock in the aggregate.

The following table reflects the calculation of basic and diluted net income per common stock:

For the three months ended

For the six months ended

June 30

June 30

    

2022

    

2021

    

2022

    

2021

Redeemable common stock

Numerator:

 

 

 

 

Net income (loss) allocable to common stock subject to possible redemption

$

(181,170)

$

(432,202)

$

1,432,611

$

(142,316)

Denominator: weighted average number of common stock

18,263,000

17,930,632

18,263,000

1,882,221

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Non-redeemable common stock

Numerator:

Net income (loss) allocable to common stock subject to possible redemption

$

(49,793)

$

(5,079)

$

393,735

$

(340,595)

Denominator: weighted average number of common stock

5,019,363

210,717

5,019,363

4,504,578

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for June 30, 2022, and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before provision for income taxes due principally to non-taxable items and the valuation allowance recorded on the Company’s deferred tax assets.

Recent Accounting Standards

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards update, if currently adopted, would have a material effect on the Company’s financial statements.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables)
6 Months Ended
Jun. 30, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN  
Summary of common Stock issued to the public reflected on the balance sheet

    

As of June 30, 2022

    

As of December 31, 2021

(Unaudited)

(Audited)

Gross Proceeds

$

182,630,000

$

182,630,000

Less:

 

 

Proceeds allocated to public warrants

 

(9,542,418)

 

(9,542,418)

Transaction costs

 

(8,628,545)

 

(8,628,545)

Plus:

 

 

Reverse the cost allocation to warrants

 

450,846

 

450,846

Additional amount deposited into trust

1,826,300

Re-measurement of carrying value to redemption value

 

18,649,334

 

18,690,549

Common stock subject to possible redemption

 

185,385,517

 

183,570,432

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Reconciliation basic and diluted net income per common stock

For the three months ended

For the six months ended

June 30

June 30

    

2022

    

2021

    

2022

    

2021

Redeemable common stock

Numerator:

 

 

 

 

Net income (loss) allocable to common stock subject to possible redemption

$

(181,170)

$

(432,202)

$

1,432,611

$

(142,316)

Denominator: weighted average number of common stock

18,263,000

17,930,632

18,263,000

1,882,221

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

Non-redeemable common stock

Numerator:

Net income (loss) allocable to common stock subject to possible redemption

$

(49,793)

$

(5,079)

$

393,735

$

(340,595)

Denominator: weighted average number of common stock

5,019,363

210,717

5,019,363

4,504,578

Basic and diluted net income (loss) per common stock

$

(0.01)

$

(0.02)

$

0.08

$

(0.08)

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2022
FAIR VALUE MEASUREMENTS  
Schedule of company's assets that are measured at fair value on a recurring basis

The following table presents information about the Company’s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of June 30 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

    

Quoted Prices in

    

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

    

(Level 3)

(Unaudited)

(Unaudited)

(Unaudited)

Asset:

Marketable securities held in Trust Account

 

$

185,439,396

 

$

$

Warrant Liabilities:

Public Warrants

$

1,734,985

$

$

Private Placement Warrants

$

$

$

129,280

Quoted Prices in

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

(Level 1)

(Level 2)

(Level 3)

    

(Audited)

    

(Audited)

    

(Audited)

Asset:

 

  

 

  

 

  

Marketable securities held in Trust Account

$

183,570,432

$

$

Warrant Liabilities:

 

  

 

  

 

  

Public Warrants

$

5,478,900

$

$

Private Placement Warrants

$

$

$

294,848

Schedule of quantitative information regarding Level 3 fair value measurements inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:

    

    

December 31, 2021

    

June 30, 2022

June 11, 2021

(Audited)

(Unaudited)

(Public Warrants

and

Private Warrants)

    

Private Warrants

Private Warrants

Exercise price

$

11.50

$

11.50

$

11.50

Share price

$

10.00

$

9.91

$

10.09

Expected term (years)

5.0

5.12

 

5.20

Probability of Acquisition

75.0

%

90.0

%

70.0

%

Volatility

18.0

%

20.0

%

 

7.6

%

Risk-free rate

0.81

%

1.26

%

2.97

%

Dividend yield (per share)

0.00

%

0.00

%

0.00

%

Schedule of change in the fair value of the warrant liabilities

The change in the fair value of the derivative warrant liabilities for the period from June 11, 2021 (Initial Public Offering) through June 30, 2022, is summarized as follows:

    

Private Warrant

    

Public Warrant

    

Warrant Liability

Fair value as of June 11, 2021 (Initial Public Offering)

$

227,622

$

8,882,500

$

9,110,122

Change in valuation inputs or other assumptions(1)

14,153

541,208

555,361

Fair value as of June 30, 2021

$

241,775

$

9,423,708

$

9,665,483

Change in valuation inputs or other assumptions(1)(2)

(127,919)

(5,151,903)

(5,259,822)

Fair value as of September 30, 2021

$

113,856

$

4,291,805

$

4,405,661

Change in valuation inputs or other assumptions(1)(2)

180,992

1,187,095

1,368,087

Fair value as of December 31, 2021

$

294,848

$

5,478,900

$

5,773,748

Change in valuation inputs or other assumptions(1)(2)

(97,527)

(3,196,025)

(3,293,552)

Fair value as of March 31, 2022 (unaudited)

$

197,321

$

2,282,875

$

2,480,196

Change in valuation inputs or other assumptions(1)(2)

(68,041)

(547,890)

(615,931)

Fair value as of June 30, 2022 (unaudited)

$

129,280

$

1,734,985

$

1,864,265

(1)Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations.
(2)Changes are due to the use of quoted prices in an active market (Level 1) and the use of unobservable inputs based on assessment of the assumptions (Level 3) for Public Warrants (after becoming actively traded) and Private Placement Warrants, respectively.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
Jun. 06, 2022
USD ($)
$ / shares
Jun. 16, 2021
USD ($)
$ / shares
shares
Jun. 11, 2021
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
item
D
$ / shares
Jun. 30, 2021
USD ($)
Jan. 22, 2022
USD ($)
Dec. 31, 2021
USD ($)
Subsidiary, Sale of Stock [Line Items]                  
Condition for future business combination number of businesses minimum | item           1      
Purchase price, per unit | $ / shares $ 10.00       $ 10.00 $ 10.00      
Investment of cash into Trust Account           $ 1,826,300 $ 183,543,150    
Transaction Costs $ (8,628,545)       $ (8,628,545) (8,628,545)     $ (8,628,545)
Deferred underwriting fees 5,935,475       5,935,475 5,935,475     5,935,475
Cash 83,302       83,302 $ 83,302     $ 257,271
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account           80.00%      
Condition For Future Business Combination Threshold Percentage Ownership           50      
Condition For Future Business Combination Threshold Net Tangible Assets $ 5,000,001       $ 5,000,001 $ 5,000,001      
Redemption limit percentage without prior consent           15.00%      
Share redemption price of shares | $ / shares $ 10.05       $ 10.05 $ 10.05      
Redemption of shares calculated based on business days prior to consummation of business combination (in days) | D           5      
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)           100.00%      
Maximum allowed dissolution expenses           $ 50,000      
Working capital           (5,468,441)      
Maximum borrowing capacity of related party promissory note               $ 1,500,000  
Proceeds from promissory note - related party $ 1,040,000                
Additional amount deposited into trust   $ 1,826,300       $ 1,826,300      
Per share value of common stock subject to possible redemption deposited into trust | $ / shares   $ 0.10     $ 0.10        
Extended term to consummate Business Combination   3 months       3 months      
IPO                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Private Units (in shares) | shares       17,000,000          
Purchase price, per unit | $ / shares     $ 10.00 $ 10.00          
Proceeds from issuance initial public offering       $ 170,000,000          
Investment of cash into Trust Account     $ 182,630,000            
Transaction Costs     8,628,545            
Underwriting fees     2,282,875            
Deferred underwriting fees     5,935,475            
Other offering costs     $ 410,195            
Cash $ 83,302       $ 83,302 $ 83,302      
Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Private Units (in shares) | shares     453,613            
Purchase price, per unit | $ / shares     $ 10.00            
Proceeds from issuance of private placement     $ 4,536,130            
Private Placement | Private Placement Units                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Private Units (in shares) | shares       431,510          
Purchase price, per unit | $ / shares       $ 10.00          
Proceeds from issuance of private placement       $ 4,315,100          
Over-allotment option                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Private Units (in shares) | shares     1,263,000 18,263,000          
Purchase price, per unit | $ / shares     $ 10.00            
Over-allotment option | Private Placement Units                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Private Units (in shares) | shares       22,103          
Purchase price, per unit | $ / shares       $ 10.00          
Proceeds from issuance of private placement       $ 221,025          
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 06, 2022
Jun. 30, 2022
Dec. 31, 2021
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN      
Gross Proceeds   $ 182,630,000 $ 182,630,000
Proceeds allocated to public warrants   (9,542,418) (9,542,418)
Transaction costs   (8,628,545) (8,628,545)
Reverse the cost allocation to warrants   450,846 450,846
Re-measurement of carrying value to redemption value   18,649,334 18,690,549
Additional amount deposited into trust $ 1,826,300 1,826,300  
Common stock subject to possible redemption   $ 185,385,517 $ 183,570,432
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Cash $ 83,302 $ 257,271
Cash equivalents $ 0 0
Number of warrants to purchase shares issued 9,538,306  
Unrecognized tax benefits accrued for interest and penalties $ 0 $ 0
Federal Depository Insurance $ 250,000  
Public Warrants    
Number of warrants to purchase shares issued 9,131,500  
Private Placement Warrants    
Number of warrants to purchase shares issued 226,806  
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Common stock subject to redemption        
Numerator:        
Net income (loss) allocable to common stock subject to possible redemption $ (181,170) $ (432,202) $ 1,432,611 $ (142,316)
Denominator:        
Weighted average number of common stock, basic 18,263,000 17,930,632 18,263,000 1,882,221
Weighted average number of common stock, Diluted 18,263,000 17,930,632 18,263,000 1,882,221
Basic net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Diluted net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Non-redeemable common stock        
Numerator:        
Net income (loss) allocable to common stock subject to possible redemption $ (49,793) $ (5,079) $ 393,735 $ (340,595)
Denominator:        
Weighted average number of common stock, basic 5,019,363 210,717 5,019,363 4,504,578
Weighted average number of common stock, Diluted 5,019,363 210,717 5,019,363 4,504,578
Basic net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
Diluted net income (loss) per common stock $ (0.01) $ (0.02) $ 0.08 $ (0.08)
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
INITIAL PUBLIC OFFERING (Details) - $ / shares
Jun. 16, 2021
Jun. 11, 2021
Jun. 08, 2021
Jun. 30, 2022
Jun. 08, 2022
Subsidiary, Sale of Stock [Line Items]          
Purchase price, per unit       $ 10.00  
IPO          
Subsidiary, Sale of Stock [Line Items]          
Number of units sold   17,000,000      
Number of units sold including partial exercise by underwriters     18,263,000    
Purchase price, per unit $ 10.00 $ 10.00      
Number of shares in a unit     1    
Number of shares issuable per warrant     0.5    
IPO | Public Warrants          
Subsidiary, Sale of Stock [Line Items]          
Number of warrants in a unit     0.5    
Exercise price of warrants         $ 11.50
Over-allotment option          
Subsidiary, Sale of Stock [Line Items]          
Number of units sold 1,263,000 18,263,000      
Purchase price, per unit $ 10.00        
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
PRIVATE PLACEMENT (Details) - USD ($)
6 Months Ended
Jun. 16, 2021
Jun. 30, 2021
Jun. 30, 2022
Subsidiary, Sale of Stock [Line Items]      
Number of warrants to purchase shares issued     9,538,306
Aggregate purchase price   $ 4,536,125  
Private Placement Warrants      
Subsidiary, Sale of Stock [Line Items]      
Number of warrants to purchase shares issued     226,806
Private Placement | Private Placement Warrants      
Subsidiary, Sale of Stock [Line Items]      
Number of warrants to purchase shares issued 453,613    
Price of warrants $ 10.00    
Aggregate purchase price $ 4,536,125    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS - Founder Shares (Details)
3 Months Ended
Jun. 08, 2021
D
$ / shares
shares
Jan. 15, 2021
USD ($)
shares
Mar. 31, 2021
USD ($)
Jun. 30, 2022
shares
Dec. 31, 2021
shares
Jun. 16, 2021
shares
Related Party Transaction [Line Items]            
Aggregate purchase price | $     $ 25,000      
Common shares, shares issued       5,019,363 5,019,363  
Common shares, shares outstanding       5,019,363 5,019,363  
Founder Shares            
Related Party Transaction [Line Items]            
Shares subject to forfeiture           321,750
Common shares, shares issued       4,565,750    
Common shares, shares outstanding       4,565,750    
Founder Shares | Sponsor            
Related Party Transaction [Line Items]            
Aggregate purchase price | $   $ 25,000        
Number of shares issued   5,750,000        
Share dividend 862,500          
Aggregate number of shares owned 4,887,500          
Shares subject to forfeiture 637,500          
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders 20.00%          
Restrictions on transfer period of time after business combination completion 6 months          
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares $ 12.00          
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D 20          
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D 30          
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)
6 Months Ended
Jan. 22, 2022
Jun. 30, 2022
Dec. 31, 2021
Jan. 31, 2021
Related Party Transaction [Line Items]        
Maximum borrowing capacity of related party promissory note $ 1,500,000      
Promissory Note with Related Party        
Related Party Transaction [Line Items]        
Maximum borrowing capacity of related party promissory note       $ 300,000
Promissory Note with Related Party | Sponsor        
Related Party Transaction [Line Items]        
Outstanding balance of related party note   $ 0 $ 0  
Administrative Support Agreement        
Related Party Transaction [Line Items]        
Expenses per month   10,000    
Amount due to related party   40,000 $ 0  
Related Party Loans        
Related Party Transaction [Line Items]        
Expenses incurred and paid $ 1,500,000      
Interest rate 8.00%      
Amount outstanding   1,066,586    
Interest expense accrued   26,586    
Related Party Loans | Working Capital Loans        
Related Party Transaction [Line Items]        
Loan conversion agreement warrant   $ 1,500,000    
Price of warrant   $ 10.00    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS - Extension loan (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 06, 2022
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 09, 2022
Related Party Transaction [Line Items]          
IPO price per Unit   $ 10.00 $ 10.00    
Additional amount deposited into trust $ 1,826,300   $ 1,826,300    
Per share value of common stock subject to possible redemption deposited into trust $ 0.10 $ 0.10      
Extended term to consummate Business Combination 3 months   3 months    
Amount outstanding   $ 1,826,300 $ 1,826,300    
Amount deposited into trust account     $ 1,826,300 $ 183,543,150  
Extension Loan          
Related Party Transaction [Line Items]          
Percentage of shares redeemed     100.00%    
Maximum interest to pay dissolution expenses     $ 50,000    
IPO price per Unit   $ 10.00 $ 10.00    
Additional amount deposited into trust $ 1,826,300        
Per share value of common stock subject to possible redemption deposited into trust $ 0.10        
Aggregate principal amount         $ 1,826,300
Amount outstanding   $ 1,826,300 $ 1,826,300    
Amount deposited into trust account     $ 1,826,300    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES (Details) - item
6 Months Ended
Jun. 30, 2022
Jan. 04, 2021
Loss Contingencies [Line Items]    
Maximum number of demands for registration of securities   3
Minimum    
Loss Contingencies [Line Items]    
Piggyback registration rights term 5 years  
Maximum    
Loss Contingencies [Line Items]    
Piggyback registration rights term 7 years  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANT LIABILITY (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
D
$ / shares
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Jun. 10, 2021
USD ($)
Class of Warrant or Right [Line Items]            
Warrants issued | shares 9,358,306          
Warrant Liability | $ $ 1,864,265 $ 2,480,196 $ 5,773,748 $ 4,405,661 $ 9,665,483 $ 9,110,122
Private Placement Warrants            
Class of Warrant or Right [Line Items]            
Warrants issued | shares 226,806          
Warrant Liability | $ $ 129,280 197,321 294,848 113,856 241,775 227,622
Public Warrants            
Class of Warrant or Right [Line Items]            
Warrants issued | shares 9,131,500          
Minimum threshold written notice period for redemption of public warrants 30 days          
Public Warrants expiration term 5 years          
Maximum period after business combination in which to file registration statement 20 days          
Period of time within which registration statement is expected to become effective 60 days          
Restrictions on transfer period of time after business combination completion 30 days          
Warrant Liability | $ $ 1,734,985 $ 2,282,875 $ 5,478,900 $ 4,291,805 $ 9,423,708 $ 8,882,500
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00            
Class of Warrant or Right [Line Items]            
Minimum threshold written notice period for redemption of public warrants 30 days          
Share price trigger used to measure dilution of warrant | $ / shares $ 18.00          
Redemption price per public warrant (in dollars per share) | $ / shares $ 0.01          
Redemption period 30 days          
Threshold trading days for redemption of public warrants 20          
Threshold consecutive trading days for redemption of public warrants 30          
Threshold number of business days before sending notice of redemption to warrant holders 3          
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00            
Class of Warrant or Right [Line Items]            
Minimum threshold written notice period for redemption of public warrants 30 days          
Share price trigger used to measure dilution of warrant | $ / shares $ 10.00          
Redemption price per public warrant (in dollars per share) | $ / shares $ 0.10          
Redemption period 30 days          
Threshold trading days for redemption of public warrants 20          
Threshold consecutive trading days for redemption of public warrants 30          
Threshold number of business days before sending notice of redemption to warrant holders 3          
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details)
Jun. 30, 2022
Vote
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Class of Stock [Line Items]    
Common shares, shares authorized (in shares) 100,000,000 100,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares, votes per share | Vote 1  
Common shares, shares issued (in shares) 5,019,363 5,019,363
Common shares, shares outstanding (in shares) 5,019,363 5,019,363
Common stock subject to redemption    
Class of Stock [Line Items]    
Temporary equity, shares outstanding 18,263,000 18,263,000
Common Stock    
Class of Stock [Line Items]    
Common shares, shares authorized (in shares) 10,000,000  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred shares, shares authorized 1,000,000 1,000,000
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred shares, shares issued 0 0
Preferred shares, shares outstanding 0 0
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Details) - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Jun. 10, 2021
Assets:            
Cash held in the Trust Account $ 83,302   $ 257,271      
Marketable securities held in Trust Account 185,439,396   183,570,432      
Warrant Liabilities:            
Warrant Liability $ 1,864,265 $ 2,480,196 5,773,748 $ 4,405,661 $ 9,665,483 $ 9,110,122
Warrants issued 9,358,306          
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Warrant Liability          
Public Warrants            
Warrant Liabilities:            
Warrant Liability $ 1,734,985 2,282,875 5,478,900 4,291,805 9,423,708 8,882,500
Warrants issued 9,131,500          
Private Placement Warrants            
Warrant Liabilities:            
Warrant Liability $ 129,280 $ 197,321 294,848 $ 113,856 $ 241,775 $ 227,622
Warrants issued 226,806          
Warrants.            
Warrant Liabilities:            
Derivative liability $ 1,864,265          
U.S. Treasury Securities            
Assets:            
Cash held in the Trust Account 185,439,396   183,570,432      
Level 1 | Recurring            
Assets:            
Marketable securities held in Trust Account 185,439,396   183,570,432      
Level 1 | Recurring | Public Warrants            
Warrant Liabilities:            
Warrant Liability 1,734,985   5,478,900      
Level 3 | Recurring | Private Placement Warrants            
Warrant Liabilities:            
Warrant Liability $ 129,280   $ 294,848      
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) - Level 3
Jun. 30, 2022
Dec. 31, 2021
Jun. 11, 2021
Exercise price | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     11.50
Exercise price | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 11.50 11.50  
Share price | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     10.00
Share price | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 10.09 9.91  
Expected term (years) | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     5.0
Expected term (years) | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 5.20 5.12  
Probability of Acquisition | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     75.0
Probability of Acquisition | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 70.0 90.0  
Volatility | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     18.0
Volatility | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 7.6 20.0  
Risk-free rate | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     0.81
Risk-free rate | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 2.97 1.26  
Dividend yield | Public Warrants and Private Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input     0.00
Dividend yield | Private Placement Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative Liability, Measurement Input 0.00 0.00  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 10, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                  
Warrant Liability $ 9,665,483 $ 1,864,265 $ 2,480,196 $ 5,773,748 $ 4,405,661 $ 9,665,483 $ 1,864,265 $ 9,665,483 $ 9,110,122
Change in fair value of warrant liability 555,361 (615,931) (3,293,552) 1,368,087 (5,259,822) (116,216) (3,909,483) (116,216)  
Public Warrants                  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                  
Warrant Liability 9,423,708 1,734,985 2,282,875 5,478,900 4,291,805 9,423,708 1,734,985 9,423,708 8,882,500
Change in fair value of warrant liability 541,208 (547,890) (3,196,025) 1,187,095 (5,151,903)        
Private Placement Warrants                  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                  
Warrant Liability 241,775 129,280 197,321 294,848 113,856 $ 241,775 $ 129,280 $ 241,775 $ 227,622
Change in fair value of warrant liability $ 14,153 $ (68,041) $ (97,527) $ 180,992 $ (127,919)        
XML 48 gacqu-20220630x10q_htm.xml IDEA: XBRL DOCUMENT 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2022-06-30 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2021-12-31 0001846288 gacqu:CommonClassaSubjectToRedemptionMember 2022-06-30 0001846288 gacqu:CommonClassaSubjectToRedemptionMember 2021-12-31 0001846288 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001846288 gacqu:FounderSharesMember gacqu:SponsorMember 2021-01-15 2021-01-15 0001846288 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001846288 us-gaap:RetainedEarningsMember 2022-06-30 0001846288 us-gaap:RetainedEarningsMember 2022-03-31 0001846288 us-gaap:RetainedEarningsMember 2021-12-31 0001846288 us-gaap:RetainedEarningsMember 2021-06-30 0001846288 us-gaap:RetainedEarningsMember 2021-03-31 0001846288 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001846288 2021-03-31 0001846288 us-gaap:RetainedEarningsMember 2020-12-31 0001846288 gacqu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001846288 gacqu:PublicWarrantsMember 2022-03-31 0001846288 gacqu:PrivatePlacementWarrantsMember 2022-03-31 0001846288 2022-03-31 0001846288 gacqu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001846288 gacqu:PublicWarrantsMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-12-31 0001846288 gacqu:PublicWarrantsMember 2021-09-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-09-30 0001846288 2021-09-30 0001846288 gacqu:PublicWarrantsMember 2021-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-06-30 0001846288 gacqu:PublicWarrantsMember 2021-06-10 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-06-10 0001846288 2021-06-10 0001846288 us-gaap:PrivatePlacementMember 2021-06-16 0001846288 us-gaap:OverAllotmentOptionMember 2021-06-16 0001846288 gacqu:PrivatePlacementUnitsMember us-gaap:PrivatePlacementMember 2021-06-11 0001846288 gacqu:PrivatePlacementUnitsMember us-gaap:OverAllotmentOptionMember 2021-06-11 0001846288 us-gaap:IPOMember 2021-06-11 0001846288 us-gaap:CommonStockMember 2022-03-31 0001846288 us-gaap:CommonStockMember 2021-12-31 0001846288 us-gaap:CommonStockMember 2021-06-30 0001846288 us-gaap:CommonStockMember 2021-03-31 0001846288 2022-06-30 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-06-16 2021-06-16 0001846288 gacqu:PromissoryNoteWithRelatedPartyMember gacqu:SponsorMember 2022-06-30 0001846288 gacqu:PromissoryNoteWithRelatedPartyMember gacqu:SponsorMember 2021-12-31 0001846288 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001846288 2021-01-01 2021-03-31 0001846288 gacqu:PublicWarrantsMember 2022-04-01 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2022-04-01 2022-06-30 0001846288 gacqu:PublicWarrantsMember 2022-01-01 2022-03-31 0001846288 gacqu:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001846288 gacqu:PublicWarrantsMember 2021-10-01 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-10-01 2021-12-31 0001846288 2021-10-01 2021-12-31 0001846288 gacqu:PublicWarrantsMember 2021-07-01 2021-09-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-07-01 2021-09-30 0001846288 2021-07-01 2021-09-30 0001846288 gacqu:PublicWarrantsMember 2021-06-11 2021-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2021-06-11 2021-06-30 0001846288 2021-06-11 2021-06-30 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2022-04-01 2022-06-30 0001846288 gacqu:CommonStockNotSubjectToRedemptionMember 2022-04-01 2022-06-30 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2022-01-01 2022-06-30 0001846288 gacqu:CommonStockNotSubjectToRedemptionMember 2022-01-01 2022-06-30 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2021-04-01 2021-06-30 0001846288 gacqu:CommonStockNotSubjectToRedemptionMember 2021-04-01 2021-06-30 0001846288 gacqu:CommonStockSubjectToRedemptionMember 2021-01-01 2021-06-30 0001846288 gacqu:CommonStockNotSubjectToRedemptionMember 2021-01-01 2021-06-30 0001846288 gacqu:AdministrativeSupportAgreementMember 2022-06-30 0001846288 gacqu:AdministrativeSupportAgreementMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:ProbabilityOfAcquisitionMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:MeasurementInputStockPriceMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:ProbabilityOfAcquisitionMember 2021-12-31 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:MeasurementInputStockPriceMember 2021-12-31 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:ProbabilityOfAcquisitionMember 2021-06-11 0001846288 gacqu:PublicAndPrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member gacqu:MeasurementInputStockPriceMember 2021-06-11 0001846288 us-gaap:WarrantMember 2022-06-30 0001846288 gacqu:ExtensionLoanMember 2022-06-09 0001846288 gacqu:FounderSharesMember 2022-06-30 0001846288 us-gaap:CommonStockMember 2022-06-30 0001846288 gacqu:PublicWarrantsMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember 2022-06-30 0001846288 us-gaap:IPOMember 2021-06-08 0001846288 gacqu:PublicWarrantsMember us-gaap:IPOMember 2022-06-08 0001846288 2021-06-30 0001846288 2020-12-31 0001846288 us-gaap:IPOMember 2022-06-30 0001846288 us-gaap:USTreasurySecuritiesMember 2022-06-30 0001846288 us-gaap:USTreasurySecuritiesMember 2021-12-31 0001846288 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001846288 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001846288 us-gaap:PrivatePlacementMember 2021-06-16 2021-06-16 0001846288 us-gaap:OverAllotmentOptionMember 2021-06-16 2021-06-16 0001846288 gacqu:PrivatePlacementUnitsMember us-gaap:PrivatePlacementMember 2021-06-11 2021-06-11 0001846288 gacqu:PrivatePlacementUnitsMember us-gaap:OverAllotmentOptionMember 2021-06-11 2021-06-11 0001846288 us-gaap:OverAllotmentOptionMember 2021-06-11 2021-06-11 0001846288 us-gaap:IPOMember 2021-06-11 2021-06-11 0001846288 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001846288 srt:MinimumMember 2022-01-01 2022-06-30 0001846288 srt:MaximumMember 2022-01-01 2022-06-30 0001846288 2021-01-01 2021-12-31 0001846288 gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member gacqu:PublicWarrantsMember 2022-06-30 0001846288 gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member gacqu:PublicWarrantsMember 2022-06-30 0001846288 gacqu:AdministrativeSupportAgreementMember 2022-01-01 2022-06-30 0001846288 gacqu:ExtensionLoanMember 2022-06-06 2022-06-06 0001846288 gacqu:FounderSharesMember gacqu:SponsorMember 2021-06-08 2021-06-08 0001846288 us-gaap:IPOMember 2021-06-16 2021-06-16 0001846288 gacqu:PublicWarrantsMember us-gaap:IPOMember 2021-06-08 2021-06-08 0001846288 gacqu:FounderSharesMember 2021-06-16 0001846288 us-gaap:IPOMember 2021-06-08 2021-06-08 0001846288 2021-01-04 0001846288 gacqu:ExtensionLoanMember 2022-01-01 2022-06-30 0001846288 2022-01-22 0001846288 gacqu:PromissoryNoteWithRelatedPartyMember 2021-01-31 0001846288 gacqu:RelatedPartyLoansMember 2022-01-22 2022-01-22 0001846288 gacqu:RelatedPartyLoansMember 2022-06-30 0001846288 gacqu:ExtensionLoanMember 2022-06-30 0001846288 2022-06-06 2022-06-06 0001846288 2021-12-31 0001846288 us-gaap:IPOMember 2021-06-16 0001846288 2022-06-30 0001846288 gacqu:WorkingCapitalLoansMember gacqu:RelatedPartyLoansMember 2022-06-30 0001846288 gacqu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-06-16 0001846288 gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member gacqu:PublicWarrantsMember 2022-01-01 2022-06-30 0001846288 gacqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member gacqu:PublicWarrantsMember 2022-01-01 2022-06-30 0001846288 gacqu:PublicWarrantsMember 2022-01-01 2022-06-30 0001846288 gacqu:FounderSharesMember gacqu:SponsorMember 2021-06-08 0001846288 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001846288 2022-04-01 2022-06-30 0001846288 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001846288 2022-01-01 2022-03-31 0001846288 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001846288 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001846288 2021-04-01 2021-06-30 0001846288 2021-01-01 2021-06-30 0001846288 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001846288 gacqu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-01-01 2022-06-30 0001846288 gacqu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember 2022-01-01 2022-06-30 0001846288 2022-08-15 0001846288 2022-01-01 2022-06-30 shares iso4217:USD iso4217:USD shares gacqu:D gacqu:Vote gacqu:item pure 5019363 5019363 3 18263000 17930632 18263000 1882221 -0.01 -0.02 0.08 -0.08 5019363 210717 5019363 4504578 -0.01 -0.02 0.08 -0.08 0 0 0001846288 --12-31 2022 Q2 false 3 0.5 0.5 P5Y 18263000 17930632 18263000 1882221 -0.01 -0.02 0.08 -0.08 5019363 210717 5019363 4504578 -0.01 -0.02 0.08 -0.08 0 0 5019363 5019363 4565750 http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares 5019363 10-Q true 2022-06-30 false 001-40468 GLOBAL CONSUMER ACQUISITION CORP. DE 86-1229973 1926 Rand Ridge Court Marietta GA 30062 404 939-9419 Common Stock GACQ NASDAQ Warrants GACQW NASDAQ Units GACQU NASDAQ Yes Yes Non-accelerated Filer true true false true 23282362 83302 257271 29750 80169 75000 188052 337440 185439396 183570432 185627448 183907872 40000 2669728 1740131 53879 113648 1066586 1826300 5656493 1853779 1864265 5773748 5935475 5935475 13456233 13563002 18263000 18263000 0.0001 0.0001 10.15 10.05 185385517 183570432 0.0001 0.0001 1000000 1000000 0 0 0.0001 0.0001 100000000 100000000 5019363 18263000 18263000 502 502 -13214804 -13226064 -13214302 -13225562 185627448 183907872 902313 104676 2044656 150306 50000 100000 -952313 -104676 -2144656 -150306 132004 2025 88104 2025 26586 26586 -615931 -116216 -3909483 -116216 450846 450846 -230964 -437281 1826345 -482911 18263000 17930632 18263000 1882221 -0.01 -0.02 0.08 -0.08 5019363 210717 5019363 4504578 -0.01 -0.02 0.08 -0.08 -478 -478 4887500 489 24511 25000 -45630 -45630 4887500 489 24511 -46108 -21108 4321343 14311924 18633267 -321750 -32 32 453613 45 4296800 4296845 -437281 -437281 5019363 502 -14795313 -14794811 5019363 502 -13226064 -13225562 2057309 2057309 -43900 -43900 5019363 502 -11124855 -11124353 -230964 -230964 0.10 -1826300 -1826300 32685 32685 5019363 502 -13214804 -13214302 1826345 -482911 88104 2025 -3909483 -116215 450846 -50419 387868 75000 40000 929597 80787 -59769 26586 -1259409 -457386 1826300 183543150 45440 -1780860 -183543150 1040000 1826300 25000 180347335 4536125 242932 2866300 184665528 -173969 664992 257271 0 83302 664992 152100293 1815085 11648045 5935475 23911 143563 9781698 9781698 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Global Consumer Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on December 28, 2020. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer products and services sectors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the three months ended June 30, 2022 the Company had not commenced any operations. All activity for the three months ended June 30, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s IPO was declared effective on June 8, 2021. On June 11, 2021, the Company consummated its IPO of 17,000,000 Units, at a price of $10.00 per unit, generating gross proceeds of $170,000,000, which is described in Note 4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the IPO, pursuant to a certain private placement unit subscription agreement, the Company completed the private sale of 431,510 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $4,315,100. In connection with the closing of the purchase of the Over-Allotment Units, the Company sold an additional 22,103 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating an additional $221,025 of gross proceeds. The sales of private placement units generated proceeds with an aggregate amount of $4,536,130 to the Company, which is described in Note 4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Following the closing of the IPO on June 11, 2021 and the partially exercised over-allotment of 18,263,000 Units by the underwriter on June 16, 2021, an amount of $182,630,000 ($10.00 per unit) from the net proceeds of the sale of the Public Units in the IPO and the sale of the Private Placement Units of 453,613 units to the Sponsor at a purchase price of $10.00 per unit, generating gross proceeds to the Company of $4,536,130, which was placed in a trust account (the “Trust Account”), and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below, except that interest earned on the Trust Account can be released to the Company to pay its tax obligations (“permitted withdrawals”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Transaction costs amounted to $8,628,545, consisting of $2,282,875 of underwriting fees, $5,935,475 deferred underwriting fee and $410,195 of other offering costs. In addition, as of June 30 2022, $83,302 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned and less any interest earned thereon that is released for taxes) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022 and December 31, 2021, the Common Stock issued to the public reflected on the balance sheet are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 182,630,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 182,630,000</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,542,418)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,542,418)</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,628,545)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,628,545)</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Reverse the cost allocation to warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 450,846</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 450,846</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additional amount deposited into trust</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,826,300</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,649,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,690,549</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Common stock subject to possible redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 185,385,517</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,570,432</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will provide its Stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Common Stock will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed (a) to vote its Common Stock, the Common Stock included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the IPO in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Common Stock) and Private Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Common Stock and Private Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the IPO if the Company fails to complete its Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.00 per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Going Concern and Management’s Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022, the Company had $83,302 in cash held in its operating account and working capital deficit of $5,468,441.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination. In addition, the Company expects to have negative cash flows from operations as it pursues an initial business combination target. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “<i style="font-style:italic;">Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i>,” the Company does not currently have adequate liquidity to sustain operations, which consist solely of pursuing a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">While the Company expects to have sufficient access to additional sources of capital if necessary, the Sponsor has signed a new Promissory Note with the Company to provide additional capital. On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. On June 30, 2022, the Company has drawn $1,040,000 from the Promissory Note. However, no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As is customary for a special purpose acquisition company, if the Company is not able to consummate a Business Combination during the Combination Period, it will cease all operations and redeem the Public Shares. Management plans to continue its efforts to consummate a Business Combination during the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and the World. As of the date the financial statement was issued, there was considerable uncertainty around the expected duration of this pandemic. The Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> 1 17000000 10.00 170000000 431510 10.00 4315100 22103 10.00 221025 4536130 18263000 182630000 10.00 453613 10.00 4536130 8628545 2282875 5935475 410195 83302 1 0.80 50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross Proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 182,630,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 182,630,000</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to public warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,542,418)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,542,418)</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,628,545)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,628,545)</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Reverse the cost allocation to warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 450,846</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 450,846</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additional amount deposited into trust</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,826,300</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Re-measurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,649,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,690,549</p></td></tr><tr><td style="vertical-align:bottom;width:63.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Common stock subject to possible redemption</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 185,385,517</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,570,432</p></td></tr></table> 182630000 182630000 -9542418 -9542418 -8628545 -8628545 450846 450846 1826300 18649334 18690549 185385517 183570432 5000001 0.15 10.05 5 1 50000 10.00 10.00 1826300 0.10 P3M 83302 -5468441 1500000 1040000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 25, 2022. The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements included in the aforementioned Form 10-K. The interim results for the six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging Growth Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had </span><span style="font-weight:normal;">$83,302</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$257,271</span><span style="font-weight:normal;"> cash held in its operating account and </span><span style="font-weight:normal;">no</span><span style="font-weight:normal;"> cash equivalents as of June 30, 2022 and December 31, 2021.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Warrant Liabilities</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Public warrants had detached from the units and were trading publicly. As such, the Company utilized the public trading price for its fair value. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Net Income (Loss) per Common Stock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income (loss) per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-weight:normal;">9,538,306</span><span style="font-weight:normal;"> shares of common stock in the aggregate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common stock:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the six months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (181,170)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (432,202)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,432,611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (142,316)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,930,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,882,221</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_bsSw5i8R2ECsQBC-WJ4pKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_7j2btQ-X9Ui9jDoeFSVw_w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cSgXUvuhtE6nlILQXIhr1g;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cWrmMtFgmUSlgAIfi4dkEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (49,793)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,079)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 393,735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (340,595)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 210,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,504,578</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_wqHStmj6pkOcghdobQIXgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_K6l0002KUE-DAvHh2Rhjvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_A_NOz0Pk-0q4MA1geeUKRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_qmhJ8KeRsk-zPLXMe-vvwA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value of Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value Measurements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:18pt;white-space:nowrap;">●</span>Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for June 30, 2022, and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before provision for income taxes due principally to non-taxable items and the valuation allowance recorded on the Company’s deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recent Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards update, if currently adopted, would have a material effect on the Company’s financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 25, 2022. The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from our audited consolidated financial statements included in the aforementioned Form 10-K. The interim results for the six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging Growth Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had </span><span style="font-weight:normal;">$83,302</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$257,271</span><span style="font-weight:normal;"> cash held in its operating account and </span><span style="font-weight:normal;">no</span><span style="font-weight:normal;"> cash equivalents as of June 30, 2022 and December 31, 2021.</span></p> 83302 257271 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivative financial instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC 825-10 “Financial Instruments”, offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Warrant Liabilities</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The 9,131,500 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 226,806 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. Public warrants had detached from the units and were trading publicly. As such, the Company utilized the public trading price for its fair value. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</p> 9131500 226806 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Common Stock Subject to Possible Redemption</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheet.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Net Income (Loss) per Common Stock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company applies the two-class method in calculating earnings per share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income (loss) per common stock is computed by dividing the pro rata net loss between the redeemable shares and the non-redeemable shares by the weighted average number of common stocks outstanding for each of the periods. The calculation of diluted income per common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable for </span><span style="font-weight:normal;">9,538,306</span><span style="font-weight:normal;"> shares of common stock in the aggregate. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table reflects the calculation of basic and diluted net income per common stock:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the six months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (181,170)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (432,202)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,432,611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (142,316)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,930,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,882,221</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_bsSw5i8R2ECsQBC-WJ4pKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_7j2btQ-X9Ui9jDoeFSVw_w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cSgXUvuhtE6nlILQXIhr1g;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cWrmMtFgmUSlgAIfi4dkEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (49,793)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,079)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 393,735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (340,595)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 210,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,504,578</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_wqHStmj6pkOcghdobQIXgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_K6l0002KUE-DAvHh2Rhjvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_A_NOz0Pk-0q4MA1geeUKRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_qmhJ8KeRsk-zPLXMe-vvwA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr></table> 9538306 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three months ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the six months ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (181,170)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (432,202)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,432,611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (142,316)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,930,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,263,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,882,221</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_bsSw5i8R2ECsQBC-WJ4pKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_7j2btQ-X9Ui9jDoeFSVw_w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cSgXUvuhtE6nlILQXIhr1g;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_cWrmMtFgmUSlgAIfi4dkEQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr><tr><td style="vertical-align:bottom;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Non-redeemable common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) allocable to common stock subject to possible redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (49,793)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,079)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 393,735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (340,595)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator: weighted average number of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 210,717</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,019,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,504,578</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:54.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_wqHStmj6pkOcghdobQIXgg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.01)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_K6l0002KUE-DAvHh2Rhjvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.02)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_A_NOz0Pk-0q4MA1geeUKRg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_qmhJ8KeRsk-zPLXMe-vvwA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.08)</p></td></tr></table> -181170 -432202 1432611 -142316 18263000 17930632 18263000 1882221 -0.01 -0.02 0.08 -0.08 -49793 -5079 393735 -340595 5019363 210717 5019363 4504578 -0.01 -0.02 0.08 -0.08 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p> 250000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value of Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value Measurements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:18pt;white-space:nowrap;">●</span>Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for June 30, 2022, and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Deferred tax liabilities and assets are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Current income taxes are based on the year’s income taxable for federal and state income tax reporting purposes. Total tax provision may differ from the statutory tax rates applied to income before provision for income taxes due principally to non-taxable items and the valuation allowance recorded on the Company’s deferred tax assets.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Recent Accounting Standards</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on December 28, 2020. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards update, if currently adopted, would have a material effect on the Company’s financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3. INITIAL PUBLIC OFFERING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Pursuant to the IPO on June 8, 2021, the Company sold 18,263,000 Units, which includes the partial exercise by the underwriter of its over-allotment option on June 16, 2021, in the amount of 1,263,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one common stock and <span style="-sec-ix-hidden:Hidden_COrdOjQbgk2S3eTu9rIP4A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase <span style="-sec-ix-hidden:Hidden_OQgflNvoPEeCIbgxHqFn5g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-half of one common stock at an exercise price of $11.50 per whole share (see Note 7).</p> 18263000 1263000 10.00 1 11.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4. PRIVATE PLACEMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Simultaneously with the closing of the IPO on June 11, 2021, and the partial exercise by the underwriter of its over-allotment option on June 16, 2021, the initial stockholders purchased an aggregate of 453,613 Placement Units at a price of $10.00 per Placement Unit, ($4,536,125 in the aggregate), from the Company in a private placement that occurred simultaneously with the closing of the IPO and the full exercise by the underwriter of its over-allotment option. The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account. The Placement Units are identical to the Units sold in the IPO, except for the placement warrants (“Placement Warrants”), as described in Note 7.</p> 453613 10.00 4536125 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5. RELATED PARTY TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Founder Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 15, 2021, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in exchange for 5,750,000 founder shares. On June 8, 2021, the Sponsor surrendered an aggregate of 862,500 shares of common stock for no consideration, resulting in an aggregate of 4,887,500 founder shares of common stock issued and outstanding. Such common stock includes an aggregate of up to 637,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the initial stockholders do not purchase any Public Shares in the Initial Public Offering and excluding the Placement Units and underlying securities). Due to the over-allotment option was partially exercised by the Underwriter on June 16, 2021, the Sponsor has agreed to return 321,750 founder shares to the Company for cancellation. The cancellation agreement has been signed on June 16, 2021, yet Continental Stock Transfer &amp; Trust Company has not processed the cancellation on their account due to processing reasons. As of June 30, 2022, there are 4,565,750 founder shares of common stock <span style="-sec-ix-hidden:Hidden_I8rKVOf6GkmPeLioPZM7wA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The initial stockholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Promissory Note – Related Party</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 31, 2021, the Sponsor issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000, to be used for payment of costs related to the Initial Public Offering. The note is non-interest bearing and payable on the earlier of (i) July 31, 2021 or (ii) the consummation of the Initial Public Offering. The Promissory Note was repaid to Sponsor in full on July 20, 2021. As of June 30, 2022 and December 31, 2021, no amounts were outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Administrative Services Arrangement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ARC Group Limited, our financial advisor, has agreed, commencing from the date that the Company’s securities are first listed on NASDAQ through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay $10,000 per month for these services. For the June 30, 2022 and December 31, 2021, the due to related party in connection with administrative service amounted $40,000 and zero, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Related Party Loans</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On January 22, 2022, a Promissory Note was signed between the Sponsor and the Company. The Sponsor agreed to borrow up to $1,500,000 principal to the Company. The principal balance of this Note shall be payable by the Company on the earlier of: (i) the date on consummation of a business combination with target businesses, or (ii) the date the Company liquidates if a business combination is not consummated. The unpaid principal amount outstanding will bear simple interest at the rate of 8% per annum. As of June 30, 2022, $1,066,586 were outstanding, of which $26,586 was interest expense accrued and payable balance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Extension Loan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will have until September 8, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On June 6, 2022, the Company issued a press release, announcing that prior to June 11, 2022, the Company’s Sponsor has deposited into the Company’s trust account $1,826,300 (representing $0.10 per redeemable share) to extend the Combination Period from June 11, 2022 to September 11, 2022. The company extend an additional three months to consummate the Business Combination, if the Company anticipates that it may not be able to consummate the initial Business Combination before September 11, 2022. On June 9, 2022, the Company issued unsecured promissory note in the aggregate principal amount of $1,826,300 to the Sponsor, in exchange for Sponsor depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination. As of June 30, 2022, $1,826,300 were outstanding and $1,826,300 were deposited into the Company’s trust account.</p> 25000 5750000 862500 4887500 637500 0.20 321750 4565750 P6M 12.00 20 30 300000 0 0 10000 40000 0 1500000 10.00 1500000 0.08 1066586 26586 1 50000 10.00 1826300 0.10 P3M 1826300 1826300 1826300 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6. COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Registration Rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on January 4, 2021, the holders of the Founder Shares, Placement units, Representative Shares are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise its demand and “piggyback” registration rights after <span style="-sec-ix-hidden:Hidden_BhfFLHPK8Emjkq2CK_28iw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span> and seven years, respectively, after the effective date of the IPO. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Right of First Refusal</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">For a period beginning on June 8, 2021 and ending 12 months from the closing of a business combination, we have granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of our Registration Statement.</p> 3 P7Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 7. WARRANT LIABILITY </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022, the Company has 9,358,306 warrants issued in the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value, with the change in fair value recognized in the Company’s statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of its initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the shares of common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60<span style="font-size:8pt;">th</span> business day after the closing of the Company’s initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.. Notwithstanding the above, if the Company’s shares of common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, it may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event it does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per common stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per warrant;</span></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:19pt;white-space:nowrap;">●</span>upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and</div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the closing price of the Company’s common stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">trading day period ending on the </span><span style="-sec-ix-hidden:Hidden_oWeiGli4OUOg5HTM8N8_jg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">third</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per common stock equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the Public Warrants:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:18pt;white-space:nowrap;">●</span>in whole and not in part;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:18pt;white-space:nowrap;">●</span>at a price of $0.10 per warrant;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:18pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><span style="display:inline-block;min-width:18pt;white-space:nowrap;">●</span>upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and</div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the closing price of the Company’s common stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$10.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period ending on the </span><span style="-sec-ix-hidden:Hidden_SdnOFoN-_0at5laj-n_Qww;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">third</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Placement Warrants and the common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounted for the 9,358,306 warrants issued in connection with the Initial Public Offering (comprised of 9,131,500 Public Warrants and 226,806 Private Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. At June 30, 2022 and December 31, 2021, the fair value of total warrant liability is $1,864,265 and $5,773,748, respectively. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</p> 9358306 9131500 226806 P30D P5Y P20D P60D 18.00 0.01 P30D P30D 18.00 20 30 10.00 0.10 P30D P30D 10.00 20 30 P30D 9358306 9131500 226806 1864265 5773748 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 8. STOCKHOLDER’S EQUITY (DEFICIT)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Common Stock </span>— The Company was authorized to issue 10,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 5,019,363 shares of Common Stock issued and outstanding, excluding 18,263,000 shares of Common Stock subject to possible redemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Shares </span>— The Company was authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of June 30, 2022 and December 31, 2021, there were no preferred shares issued or outstanding.</p> 10000000 0.0001 1 5019363 5019363 18263000 18263000 1000000 0.0001 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 9. FAIR VALUE MEASUREMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">Level 3 Inputs: Significant inputs into the valuation model are unobservable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information about the Company’s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of June 30 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 185,439,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:middle;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,734,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129,280</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,570,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,478,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 294,848</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.The Warrants are measured at fair value on a recurring basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of June 30, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $185,439,396 and $183,570,432 in U.S. Treasury Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounted for the aggregate 9,358,306 warrants issued in connection with the Initial Public Offering (the 9,131,500 Public Warrants and the 226,806 Placement Warrants) in accordance with the guidance contained in FASB ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option and the existence of the potential for net cash settlement for the warrant holders (but not all common stockholders) in the event of a tender offer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to remeasurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company utilizes a binomial Monte-Carlo simulation to estimate the fair value of the private placement warrants at each reporting period for its warrants that are not actively traded. Beginning on July 29, 2021, the Public Warrants began trading under the ticker GACQW. After this date, Public Warrant values per share were based on the observed trading price of the Public Warrants. Accordingly, as of September 30, 2021, the observable input qualifies the liability for treatment as a Level 1 liability. The Company recognized $1,864,265 for the <span style="-sec-ix-hidden:Hidden_Z0LhfEg3REOtNJ_flNsJbw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">derivative warrant liabilities</span></span> on June 30, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The estimated fair value of certain derivative warrant liabilities is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 11, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">(Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">and</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">20.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The change in the fair value of the derivative warrant liabilities for the period from June 11, 2021 (Initial Public Offering) through June 30, 2022, is summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Warrant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public Warrant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 11, 2021 (Initial Public Offering)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 227,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,882,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,110,122</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 541,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 555,361</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 241,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,423,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,665,483</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (127,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,151,903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,259,822)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113,856</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,291,805</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,405,661</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 180,992</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,368,087</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 294,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,478,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,773,748</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (97,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,293,552)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of March 31, 2022 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,321</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,282,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,480,196</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,041)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (547,890)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (615,931)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2022 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129,280</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,734,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,864,265</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes are due to the use of quoted prices in an active market (Level 1) and the use of unobservable inputs based on assessment of the assumptions (Level 3) for Public Warrants (after becoming actively traded) and Private Placement Warrants, respectively.</span></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information about the Company’s assets and derivative warrant liabilities that are measured at fair value on a recurring basis as of June 30 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 185,439,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:middle;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,734,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129,280</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted Prices in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Asset:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,570,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Warrant Liabilities:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,478,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 294,848</p></td></tr></table> 185439396 1734985 129280 183570432 5478900 294848 185439396 183570432 9358306 9131500 226806 1864265 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 11, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Audited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Unaudited)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">(Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">and</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Private Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of Acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">20.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:60.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield (per share)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> 11.50 11.50 11.50 10.00 9.91 10.09 5.0 5.12 5.20 75.0 90.0 70.0 18.0 20.0 7.6 0.81 1.26 2.97 0.00 0.00 0.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The change in the fair value of the derivative warrant liabilities for the period from June 11, 2021 (Initial Public Offering) through June 30, 2022, is summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Warrant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public Warrant</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 11, 2021 (Initial Public Offering)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 227,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,882,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,110,122</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 541,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 555,361</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 241,775</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,423,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,665,483</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (127,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,151,903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,259,822)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113,856</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,291,805</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,405,661</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 180,992</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,368,087</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 294,848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,478,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,773,748</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (97,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,196,025)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,293,552)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of March 31, 2022 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,321</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,282,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,480,196</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation inputs or other assumptions<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,041)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (547,890)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (615,931)</p></td></tr><tr><td style="vertical-align:bottom;width:57.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2022 (unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 129,280</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,734,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,864,265</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liability in the statement of operations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Changes are due to the use of quoted prices in an active market (Level 1) and the use of unobservable inputs based on assessment of the assumptions (Level 3) for Public Warrants (after becoming actively traded) and Private Placement Warrants, respectively.</span></td></tr></table> 227622 8882500 9110122 14153 541208 555361 241775 9423708 9665483 -127919 -5151903 -5259822 113856 4291805 4405661 180992 1187095 1368087 294848 5478900 5773748 -97527 -3196025 -3293552 197321 2282875 2480196 -68041 -547890 -615931 129280 1734985 1864265 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 10. SUBSEQUENT EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 50 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 155 212 1 false 39 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.gacqu.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Balance Sheets Sheet http://www.gacqu.com/role/StatementCondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Statements of Operations Sheet http://www.gacqu.com/role/StatementCondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Statements of Changes in Stockholders' Deficit Sheet http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit Condensed Statements of Changes in Stockholders' Deficit Statements 5 false false R6.htm 00305 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Parenthetical) Sheet http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical Condensed Statements of Changes in Stockholders' Deficit (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Statements of Cash Flows Sheet http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 7 false false R8.htm 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Sheet http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcern DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Notes 8 false false R9.htm 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10301 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://www.gacqu.com/role/DisclosureInitialPublicOffering INITIAL PUBLIC OFFERING Notes 10 false false R11.htm 10401 - Disclosure - PRIVATE PLACEMENT Sheet http://www.gacqu.com/role/DisclosurePrivatePlacement PRIVATE PLACEMENT Notes 11 false false R12.htm 10501 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.gacqu.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.gacqu.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 10701 - Disclosure - WARRANT LIABILITY Sheet http://www.gacqu.com/role/DisclosureWarrantLiability WARRANT LIABILITY Notes 14 false false R15.htm 10801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.gacqu.com/role/DisclosureStockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) Notes 15 false false R16.htm 10901 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.gacqu.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 11001 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.gacqu.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 30103 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables) Sheet http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernTables DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables) Tables http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcern 19 false false R20.htm 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.gacqu.com/role/DisclosureFairValueMeasurements 21 false false R22.htm 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details) Sheet http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details) Details http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernTables 22 false false R23.htm 40102 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details) Sheet http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details) Details 23 false false R24.htm 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details) Sheet http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details) Details 25 false false R26.htm 40301 - Disclosure - INITIAL PUBLIC OFFERING (Details) Sheet http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails INITIAL PUBLIC OFFERING (Details) Details http://www.gacqu.com/role/DisclosureInitialPublicOffering 26 false false R27.htm 40401 - Disclosure - PRIVATE PLACEMENT (Details) Sheet http://www.gacqu.com/role/DisclosurePrivatePlacementDetails PRIVATE PLACEMENT (Details) Details http://www.gacqu.com/role/DisclosurePrivatePlacement 27 false false R28.htm 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 28 false false R29.htm 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details) Sheet http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails RELATED PARTY TRANSACTIONS - Additional Information (Details) Details 29 false false R30.htm 40503 - Disclosure - RELATED PARTY TRANSACTIONS - Extension loan (Details) Sheet http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails RELATED PARTY TRANSACTIONS - Extension loan (Details) Details 30 false false R31.htm 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.gacqu.com/role/DisclosureCommitmentsAndContingencies 31 false false R32.htm 40701 - Disclosure - WARRANT LIABILITY (Details) Sheet http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails WARRANT LIABILITY (Details) Details http://www.gacqu.com/role/DisclosureWarrantLiability 32 false false R33.htm 40801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details) Sheet http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details) Details http://www.gacqu.com/role/DisclosureStockholdersEquityDeficit 33 false false R34.htm 40802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details) Sheet http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details) Details http://www.gacqu.com/role/DisclosureStockholdersEquityDeficit 34 false false R35.htm 40901 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables 35 false false R36.htm 40902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) Sheet http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) Details 36 false false R37.htm 40903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) Sheet http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) Details 37 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 47 fact(s) appearing in ix:hidden were eligible for transformation: gacqu:NumberOfWarrantsIssuedPerUnit, gacqu:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders, gacqu:UnderwritersOptionsRegistrationRightsPiggybackExerciseTerm, us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - gacqu-20220630x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - gacqu-20220630x10q.htm 9 gacqu-20220630x10q.htm gacqu-20220630.xsd gacqu-20220630_cal.xml gacqu-20220630_def.xml gacqu-20220630_lab.xml gacqu-20220630_pre.xml gacqu-20220630xex31d1.htm gacqu-20220630xex31d2.htm gacqu-20220630xex32d1.htm gacqu-20220630xex32d2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 55 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gacqu-20220630x10q.htm": { "axisCustom": 0, "axisStandard": 12, "contextCount": 155, "dts": { "calculationLink": { "local": [ "gacqu-20220630_cal.xml" ] }, "definitionLink": { "local": [ "gacqu-20220630_def.xml" ] }, "inline": { "local": [ "gacqu-20220630x10q.htm" ] }, "labelLink": { "local": [ "gacqu-20220630_lab.xml" ] }, "presentationLink": { "local": [ "gacqu-20220630_pre.xml" ] }, "schema": { "local": [ "gacqu-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 326, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 48, "http://www.gacqu.com/20220630": 4, "http://xbrl.sec.gov/dei/2022": 5, "total": 57 }, "keyCustom": 76, "keyStandard": 136, "memberCustom": 20, "memberStandard": 18, "nsprefix": "gacqu", "nsuri": "http://www.gacqu.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - INITIAL PUBLIC OFFERING", "role": "http://www.gacqu.com/role/DisclosureInitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - PRIVATE PLACEMENT", "role": "http://www.gacqu.com/role/DisclosurePrivatePlacement", "shortName": "PRIVATE PLACEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.gacqu.com/role/DisclosureRelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.gacqu.com/role/DisclosureCommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:WarrantLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - WARRANT LIABILITY", "role": "http://www.gacqu.com/role/DisclosureWarrantLiability", "shortName": "WARRANT LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "gacqu:WarrantLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT)", "role": "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficit", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.gacqu.com/role/DisclosureFairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.gacqu.com/role/DisclosureSubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30103 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables)", "role": "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernTables", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Balance Sheets", "role": "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "INF", "first": true, "lang": null, "name": "gacqu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_kusJL6TfOECNfThW0F7q3w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details)", "role": "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "INF", "first": true, "lang": null, "name": "gacqu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_kusJL6TfOECNfThW0F7q3w", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40102 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details)", "role": "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN - Common Stock issued to the public reflected on the balance sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "0", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_us-gaap_StatementClassOfStockAxis_gacqu_CommonStockSubjectToRedemptionMember_W6J8O_N4D0mp7UNd9IEuKA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details)", "role": "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation basic and diluted net income per common stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_us-gaap_StatementClassOfStockAxis_gacqu_CommonStockSubjectToRedemptionMember_W6J8O_N4D0mp7UNd9IEuKA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_SP-YMCmAzkGNFaPfuTKjnQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - INITIAL PUBLIC OFFERING (Details)", "role": "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "shortName": "INITIAL PUBLIC OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "gacqu:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_6_8_2021_To_6_8_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_dqWX4G-KiEWZ6zigl_YGpQ", "decimals": "INF", "lang": null, "name": "gacqu:UnitsIssuedDuringPeriodSharesNewIssuesIncludingIssuesToUnderwriter", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - PRIVATE PLACEMENT (Details)", "role": "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "shortName": "PRIVATE PLACEMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "gacqu:PrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_16_2021_us-gaap_ClassOfWarrantOrRightAxis_gacqu_PrivatePlacementWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_gWs2g5iV5Eu8Ri_IO6VkRw", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_30sueKkdAUeFKHbmVG8C1A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "role": "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_16_2021_us-gaap_RelatedPartyTransactionAxis_gacqu_FounderSharesMember_AxPUADhWwkK5wQY3WvZTbQ", "decimals": "INF", "lang": null, "name": "gacqu:NumberOfSharesSubjectToForfeiture", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_1_22_2022_nozuuldBL0KJLmDcmhvRzA", "decimals": "0", "first": true, "lang": null, "name": "gacqu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)", "role": "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "RELATED PARTY TRANSACTIONS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_1_31_2021_us-gaap_RelatedPartyTransactionAxis_gacqu_PromissoryNoteWithRelatedPartyMember_eMDmULLI80WhVBkiZ1gnmw", "decimals": "0", "lang": null, "name": "gacqu:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_SP-YMCmAzkGNFaPfuTKjnQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Balance Sheets (Parenthetical)", "role": "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_us-gaap_StatementClassOfStockAxis_gacqu_CommonStockSubjectToRedemptionMember_kzZ5VLtuPkC1lJmp9fMLbg", "decimals": "2", "lang": null, "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_SP-YMCmAzkGNFaPfuTKjnQ", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_SP-YMCmAzkGNFaPfuTKjnQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40503 - Disclosure - RELATED PARTY TRANSACTIONS - Extension loan (Details)", "role": "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "shortName": "RELATED PARTY TRANSACTIONS - Extension loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_us-gaap_RelatedPartyTransactionAxis_gacqu_ExtensionLoanMember_2sw1L6FaBU6KDwF8O4s3bg", "decimals": "2", "lang": null, "name": "gacqu:PercentageOfSharesRedeemed", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-Nzf4RU5SkCJeb-JgtVEfw", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_1_4_2021_yhPFoZfaQU6Wk5iD9R5Dcg", "decimals": "INF", "first": true, "lang": null, "name": "gacqu:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_kusJL6TfOECNfThW0F7q3w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_1_4_2021_yhPFoZfaQU6Wk5iD9R5Dcg", "decimals": "INF", "first": true, "lang": null, "name": "gacqu:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_kusJL6TfOECNfThW0F7q3w", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "gacqu:WarrantLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - WARRANT LIABILITY (Details)", "role": "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails", "shortName": "WARRANT LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "gacqu:WarrantLiabilitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_us-gaap_ClassOfWarrantOrRightAxis_gacqu_PublicWarrantsMember_h0x8nVRb20GyH0pze-nd4w", "decimals": null, "lang": "en-US", "name": "gacqu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details)", "role": "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "lang": null, "name": "gacqu:CommonStockNumberOfVotesPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_Vote_49m53Aw-BUi_EQcMK4JI9g", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_n-4uq5tTiUGJnN4ndZT29Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details)", "role": "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock Shares (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_TwKgcS07OkOEdGu3jy2upg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "role": "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_WarrantMember_LYO0Io7YSUKbNxkZyHkLIw", "decimals": "0", "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_11_2021_us-gaap_ClassOfWarrantOrRightAxis_gacqu_PublicAndPrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_QCIdsTReUUKHI-tOk7dcqQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-Nzf4RU5SkCJeb-JgtVEfw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)", "role": "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails", "shortName": "FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_11_2021_us-gaap_ClassOfWarrantOrRightAxis_gacqu_PublicAndPrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExercisePriceMember_QCIdsTReUUKHI-tOk7dcqQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-Nzf4RU5SkCJeb-JgtVEfw", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_6_30_2021_UE4zxd41K0imMONo3bt8EQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)", "role": "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "shortName": "FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_6_11_2021_To_6_30_2021_atJvAZv9V0yzz5iXJEZ4Pw", "decimals": "0", "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_wc-tr147j0a-WkpgGpZtAw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Condensed Statements of Operations", "role": "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations", "shortName": "Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_4_1_2022_To_6_30_2022_wc-tr147j0a-WkpgGpZtAw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_jPv5Sdk2GU62KS0opooIMA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Condensed Statements of Changes in Stockholders' Deficit", "role": "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "shortName": "Condensed Statements of Changes in Stockholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_TRJwPTs-WEa3a-F9SCwhUA", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_6_6_2022_To_6_6_2022_r4uvU6xRsU-XoO24t-UXSg", "decimals": "2", "first": true, "lang": null, "name": "gacqu:PerShareValueOfCommonStockSubjectToPossibleRedemptionDepositedIntoTrust", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_SP-YMCmAzkGNFaPfuTKjnQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Parenthetical)", "role": "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical", "shortName": "Condensed Statements of Changes in Stockholders' Deficit (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Statements of Cash Flows", "role": "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows", "shortName": "Condensed Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_PMJvI_vlNEuayrr0tnPx0A", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "role": "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcern", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "gacqu-20220630x10q.htm", "contextRef": "Duration_1_1_2022_To_6_30_2022_xKKtIvPDkE6zkWTkdu3kRw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 39, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "gacqu_AccretionForCommonStockToRedemptionAmountNetOfUnderwritingDiscountsAndOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accretion for common stock to redemption amount, net of underwriting discounts and offering costs.", "label": "Accretion for Common Stock to Redemption Amount, Net of Underwriting Discounts and Offering Costs", "negatedLabel": "Re-measurement for common stock to redemption amount", "verboseLabel": "Re-measurement of common stock subject to redemption" } } }, "localname": "AccretionForCommonStockToRedemptionAmountNetOfUnderwritingDiscountsAndOfferingCosts", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gacqu_AdditionalAmountDepositedIntoTrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the decrease in stockholder's equity due to additional amount deposited into trust.", "label": "Additional Amount Deposited Into Trust", "terseLabel": "Additional amount deposited into trust ($0.10 per common stock subject to possible redemption)" } } }, "localname": "AdditionalAmountDepositedIntoTrust", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gacqu_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Administrative Support Agreement.", "label": "Administrative Support Agreement" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "gacqu_AggregateNumberOfSharesOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares owned by the founders after the impact of the stock dividend.", "label": "Aggregate Number Of Shares Owned", "terseLabel": "Aggregate number of shares owned" } } }, "localname": "AggregateNumberOfSharesOwned", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "gacqu_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gacqu_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents for change in fair value of warrant liability.", "label": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "terseLabel": "Minimum threshold written notice period for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "gacqu_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant", "verboseLabel": "Price of warrants" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "gacqu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "gacqu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "gacqu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per public warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "gacqu_CommonClassaSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.", "label": "Class A Common Stock Subject to Redemption" } } }, "localname": "CommonClassaSubjectToRedemptionMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "domainItemType" }, "gacqu_CommonStockNotSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Not Subject To Redemption.", "label": "Non-redeemable common stock" } } }, "localname": "CommonStockNotSubjectToRedemptionMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "gacqu_CommonStockNumberOfVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of votes that each common share is entitled.", "label": "Common Stock, Number Of Votes Per Share", "terseLabel": "Common shares, votes per share" } } }, "localname": "CommonStockNumberOfVotesPerShare", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails" ], "xbrltype": "integerItemType" }, "gacqu_CommonStockSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing shares subject to possible redemption.", "label": "Common stock subject to redemption" } } }, "localname": "CommonStockSubjectToRedemptionMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "gacqu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition for future business combination number of businesses minimum", "terseLabel": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "integerItemType" }, "gacqu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.", "label": "Condition for future business combination threshold Net Tangible Assets", "terseLabel": "Condition For Future Business Combination Threshold Net Tangible Assets" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.", "label": "Condition for future business combination threshold Percentage Ownership", "terseLabel": "Condition For Future Business Combination Threshold Percentage Ownership" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "pureItemType" }, "gacqu_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred Offering Costs Noncurrent", "verboseLabel": "Deferred underwriting fees" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gacqu_DeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.", "label": "Deferred Underwriting Fee Payable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_DenominatorForCalculationOfEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Denominator For Calculation Of Earnings Per Share [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "DenominatorForCalculationOfEarningsPerShareAbstract", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails" ], "xbrltype": "stringItemType" }, "gacqu_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on Emerging Growth Company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gacqu_ExtendedTermToConsummateBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the extended term to consummate Business Combination.", "label": "Extended Term To Consummate Business Combination", "terseLabel": "Extended term to consummate Business Combination" } } }, "localname": "ExtendedTermToConsummateBusinessCombination", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "durationItemType" }, "gacqu_ExtensionLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for extension loans.", "label": "Extension Loan" } } }, "localname": "ExtensionLoanMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "domainItemType" }, "gacqu_ExtensionNotesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of extension note as of balance sheet date. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Extension Notes Payable, Current", "terseLabel": "Extension note", "verboseLabel": "Amount outstanding" } } }, "localname": "ExtensionNotesPayableCurrent", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gacqu_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Founder Shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "gacqu_FranchiseTaxExpense": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of franchise tax expense incurred during the period.", "label": "Franchise Tax Expense", "terseLabel": "Franchise tax" } } }, "localname": "FranchiseTaxExpense", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gacqu_FranchiseTaxPayable": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to franchise tax.", "label": "Franchise tax payable" } } }, "localname": "FranchiseTaxPayable", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gacqu_IncreaseDecreaseFranchiseTaxPayable": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of franchise tax payable.", "label": "Increase Decrease Franchise Tax Payable", "terseLabel": "Franchise tax payable" } } }, "localname": "IncreaseDecreaseFranchiseTaxPayable", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_IncreaseDecreaseInPrepaidExpensesAndOtherReceivable": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses and other receivables.", "label": "Increase (Decrease) in Prepaid Expenses and Other Receivable", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesAndOtherReceivable", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_InitialClassificationOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the initial classification of common stock subject to possible redemption in non-cash investing and financing civilities.", "label": "Initial Classification Of Common Stock Subject To Possible Redemption", "terseLabel": "Initial classification of common stock subject to possible redemption" } } }, "localname": "InitialClassificationOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_InitialClassificationOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of initial classification of warrant liability.", "label": "Initial Classification of Warrant Liability", "terseLabel": "Initial classification of warrant liability" } } }, "localname": "InitialClassificationOfWarrantLiability", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "INITIAL PUBLIC OFFERING." } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://www.gacqu.com/20220630", "xbrltype": "stringItemType" }, "gacqu_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "gacqu_InterestExpensePayableRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest expense due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Expense Payable, Related Party", "terseLabel": "Interest expense accrued" } } }, "localname": "InterestExpensePayableRelatedParty", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_InterestRateRelatedParty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the interest rate on related party transaction.", "label": "Interest Rate, Related Party", "terseLabel": "Interest rate" } } }, "localname": "InterestRateRelatedParty", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "gacqu_MaximumAllowedDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.", "label": "Maximum Allowed Dissolution Expenses", "terseLabel": "Maximum allowed dissolution expenses" } } }, "localname": "MaximumAllowedDissolutionExpenses", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity of Related Party Promissory Note", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_MaximumInterestToPayDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the maximum interest to pay dissolution expenses.", "label": "Maximum Interest To Pay Dissolution Expenses", "terseLabel": "Maximum interest to pay dissolution expenses" } } }, "localname": "MaximumInterestToPayDissolutionExpenses", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_MaximumLoansConvertibleIntoWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.", "label": "maximum Loans Convertible Into Warrants", "terseLabel": "Loan conversion agreement warrant" } } }, "localname": "MaximumLoansConvertibleIntoWarrants", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_MaximumNumberOfDemandsForRegistrationOfSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of demands for registration of securities.", "label": "Maximum Number Of Demands For Registration Of Securities", "terseLabel": "Maximum number of demands for registration of securities" } } }, "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "integerItemType" }, "gacqu_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.", "label": "Maximum Period After Business Combination In Which To File Registration Statement", "terseLabel": "Maximum period after business combination in which to file registration statement" } } }, "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "gacqu_MeasurementInputStockPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input stock price.", "label": "Share price" } } }, "localname": "MeasurementInputStockPriceMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "gacqu_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "gacqu_NumberOfSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.", "label": "Number Of Shares Subject To Forfeiture", "terseLabel": "Shares subject to forfeiture" } } }, "localname": "NumberOfSharesSubjectToForfeiture", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "gacqu_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "gacqu_NumeratorForCalculationOfEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Numerator For Calculation Of Earnings Per Share [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NumeratorForCalculationOfEarningsPerShareAbstract", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails" ], "xbrltype": "stringItemType" }, "gacqu_OfferingCostsAllocatedToWarrants": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of offering costs allocated to warrants.", "label": "Offering Costs Allocated to Warrants", "terseLabel": "Offering costs allocated to warrants" } } }, "localname": "OfferingCostsAllocatedToWarrants", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_OfferingCostsChargedToAdditionalPaidInCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering costs charged to additional paid in capital in non-cash investing and financing civilities.", "label": "Offering Costs Charged To Additional Paid In Capital", "terseLabel": "Offering costs charged to additional paid in capital" } } }, "localname": "OfferingCostsChargedToAdditionalPaidInCapital", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_OfferingCostsChargedToPromissoryNoteRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering costs charged to promissory note-related party in non-cash investing and financing civilities.", "label": "Offering Costs Charged To Promissory Note-Related Party", "terseLabel": "Offering costs charged to promissory note-related party" } } }, "localname": "OfferingCostsChargedToPromissoryNoteRelatedParty", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_PaymentsForInvestmentOfCashInTrustAccount": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow for investment of cash in trust account.", "label": "Payments for investment of cash in Trust Account", "negatedLabel": "Investment of cash in Trust Account", "terseLabel": "Investment of cash into Trust Account", "verboseLabel": "Amount deposited into trust account" } } }, "localname": "PaymentsForInvestmentOfCashInTrustAccount", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_PerShareValueOfCommonStockSubjectToPossibleRedemptionDepositedIntoTrust": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per Share Value Of Common Stock Subject To Possible Redemption Deposited Into Trust", "label": "Per Share Value Of Common Stock Subject To Possible Redemption Deposited Into Trust", "terseLabel": "Per share value of common stock subject to possible redemption deposited into trust" } } }, "localname": "PerShareValueOfCommonStockSubjectToPossibleRedemptionDepositedIntoTrust", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "perShareItemType" }, "gacqu_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.", "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination", "terseLabel": "Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)" } } }, "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "percentItemType" }, "gacqu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.", "label": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders", "terseLabel": "Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders" } } }, "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "percentItemType" }, "gacqu_PercentageOfSharesRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares redeemed.", "label": "Percentage Of Shares Redeemed", "terseLabel": "Percentage of shares redeemed" } } }, "localname": "PercentageOfSharesRedeemed", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "percentItemType" }, "gacqu_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.", "label": "Period Of Time Within Which Registration Statement Is Expected To Become Effective", "terseLabel": "Period of time within which registration statement is expected to become effective" } } }, "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "gacqu_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PRIVATE PLACEMENT." } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.gacqu.com/20220630", "xbrltype": "stringItemType" }, "gacqu_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosurePrivatePlacement" ], "xbrltype": "textBlockItemType" }, "gacqu_PrivatePlacementUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relating to private placement units.", "label": "Private Placement Units" } } }, "localname": "PrivatePlacementUnitsMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "domainItemType" }, "gacqu_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "gacqu_ProbabilityOfAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Probability of Acquisition.", "label": "Probability of Acquisition" } } }, "localname": "ProbabilityOfAcquisitionMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "gacqu_ProceedsFromExtensionNotesPayable": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from extension notes.", "label": "Proceeds from Extension Notes Payable", "terseLabel": "Proceeds from Extension notes" } } }, "localname": "ProceedsFromExtensionNotesPayable", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_ProceedsFromIssuanceOfUnitsNet": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of units net of underwriting discount.", "label": "Proceeds from Issuance of Units, Net", "terseLabel": "Proceeds from sale of units, net underwriting discount paid" } } }, "localname": "ProceedsFromIssuanceOfUnitsNet", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_PromissoryNoteWithRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note with Related Party" } } }, "localname": "PromissoryNoteWithRelatedPartyMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "gacqu_PublicAndPrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Public and Private placement warrants.", "label": "Public Warrants and Private Warrants" } } }, "localname": "PublicAndPrivatePlacementWarrantsMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "gacqu_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "gacqu_RealizedAndUnrealizedGainLossOnInvestments": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain loss on investments.", "label": "Realized and Unrealized Gain Loss On Investments", "negatedLabel": "Realized and unrealized gain from marketable securities held in Trust Account", "terseLabel": "Realized and unrealized gain from marketable securities held in Trust Account" } } }, "localname": "RealizedAndUnrealizedGainLossOnInvestments", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gacqu_RedemptionLimitPercentageWithoutPriorConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The limit on the percentage of shares which may be redeemed with out prior consent of the reporting entity.", "label": "Redemption Limit Percentage Without Prior Consent", "terseLabel": "Redemption limit percentage without prior consent" } } }, "localname": "RedemptionLimitPercentageWithoutPriorConsent", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "percentItemType" }, "gacqu_RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the redemption of shares calculated based on number of business days prior to consummation of business combination.", "label": "Redemption of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination", "terseLabel": "Redemption of shares calculated based on business days prior to consummation of business combination (in days)" } } }, "localname": "RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "integerItemType" }, "gacqu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.", "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "gacqu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.", "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "gacqu_RedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "RedemptionPeriod", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "gacqu_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "gacqu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The contractual monthly amount to be paid for support services.", "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month", "terseLabel": "Expenses per month" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.", "label": "Restrictions On Transfer Period Of Time After Business Combination Completion", "terseLabel": "Restrictions on transfer period of time after business combination completion" } } }, "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "gacqu_SaleOfStockOtherOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "SaleOfStockOtherOfferingCosts", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_SaleOfStockUnderwritingFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_SharePricetriggerUsedToMeasureDilutionOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.", "label": "Share Price Trigger Used To Measure Dilution Of Warrant", "terseLabel": "Share price trigger used to measure dilution of warrant" } } }, "localname": "SharePricetriggerUsedToMeasureDilutionOfWarrant", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "gacqu_SharesRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share redemption price of shares.", "label": "Shares Redemption Price Per Share", "terseLabel": "Share redemption price of shares" } } }, "localname": "SharesRedemptionPricePerShare", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "perShareItemType" }, "gacqu_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for sponsor.", "label": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "gacqu_TemporaryEquityAdditionalAmountDepositedIntoTrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the additional amount deposited into trust.", "label": "Temporary Equity, Additional Amount Deposited Into Trust", "terseLabel": "Additional amount deposited into trust" } } }, "localname": "TemporaryEquityAdditionalAmountDepositedIntoTrust", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails", "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gacqu_TemporaryEquityProceedsAllocatedToWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds allocated from temporary equity to warrants.", "label": "Temporary Equity , Proceeds Allocated To Warrants", "terseLabel": "Proceeds allocated to public warrants" } } }, "localname": "TemporaryEquityProceedsAllocatedToWarrants", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_TemporaryEquityReverseCostAllocation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reverse the cost allocation to warrants.", "label": "Temporary Equity Reverse Cost Allocation", "terseLabel": "Reverse the cost allocation to warrants" } } }, "localname": "TemporaryEquityReverseCostAllocation", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account.", "label": "Threshold Minimum Aggregate Fair Market Value As Percentage Of Net Assets Held In trust Account", "terseLabel": "Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account" } } }, "localname": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "percentItemType" }, "gacqu_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of business days before sending notice of redemption to warrant holders.", "label": "Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders", "terseLabel": "Threshold number of business days before sending notice of redemption to warrant holders" } } }, "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "integerItemType" }, "gacqu_TransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "terseLabel": "Transaction costs", "totalLabel": "Transaction Costs" } } }, "localname": "TransactionCosts", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails", "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger", "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "gacqu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "gacqu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.", "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days", "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "gacqu_UnderwritersOptionsRegistrationRightsPiggybackExerciseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Duration for underwriters to exercise its demands and piggyback registration rights.", "label": "Underwriters Options, Registration Rights, Piggyback Exercise Term", "terseLabel": "Piggyback registration rights term" } } }, "localname": "UnderwritersOptionsRegistrationRightsPiggybackExerciseTerm", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "durationItemType" }, "gacqu_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units, each consisting of one share of Class A Common Stock and one-half of one Warrant.", "label": "Units" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "gacqu_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "terseLabel": "Sale of Private Units (in shares)", "verboseLabel": "Number of units sold" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "gacqu_UnitsIssuedDuringPeriodSharesNewIssuesIncludingIssuesToUnderwriter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units Issued During Period Shares New Issues, Including Issues to Underwriter", "label": "Units Issued During Period Shares New Issues, Including Issues to Underwriter", "terseLabel": "Number of units sold including partial exercise by underwriters" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssuesIncludingIssuesToUnderwriter", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "gacqu_UnitsIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new unit issued during the period.", "label": "Units Issued During Period, Value, New Issues", "terseLabel": "Sale of Private Units" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssues", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gacqu_WarrantLiabilitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for warrants.", "label": "Warrant Liabilities Disclosure Text Block", "terseLabel": "WARRANT LIABILITY" } } }, "localname": "WarrantLiabilitiesDisclosureTextBlock", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiability" ], "xbrltype": "textBlockItemType" }, "gacqu_WarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WARRANT LIABILITY", "label": "WARRANT LIABILITY" } } }, "localname": "WarrantLiabilityAbstract", "nsuri": "http://www.gacqu.com/20220630", "xbrltype": "stringItemType" }, "gacqu_WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price.", "label": "Warrants" } } }, "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "gacqu_WithdrawFromTrustAccountForFranchiseTaxPayment": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from withdraw of amount from Trust Account for Franchise tax payment.", "label": "Withdraw From Trust Account For Franchise Tax Payment", "terseLabel": "Withdraw from Trust Account for Franchise tax payment" } } }, "localname": "WithdrawFromTrustAccountForFranchiseTaxPayment", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gacqu_WorkingCapitalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represents the working capital.", "label": "Working Capital Amount", "terseLabel": "Working capital" } } }, "localname": "WorkingCapitalAmount", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "gacqu_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for working capital loans.\n.", "label": "Working Capital Loans" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://www.gacqu.com/20220630", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r135", "r137", "r138", "r139", "r157", "r170", "r204", "r206", "r290", "r291", "r292", "r293", "r294", "r295", "r314", "r345", "r346", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r135", "r137", "r138", "r139", "r157", "r170", "r204", "r206", "r290", "r291", "r292", "r293", "r294", "r295", "r314", "r345", "r346", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r128", "r135", "r137", "r138", "r139", "r157", "r170", "r194", "r204", "r206", "r208", "r209", "r210", "r290", "r291", "r292", "r293", "r294", "r295", "r314", "r345", "r346", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r128", "r135", "r137", "r138", "r139", "r157", "r170", "r194", "r204", "r206", "r208", "r209", "r210", "r290", "r291", "r292", "r293", "r294", "r295", "r314", "r345", "r346", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r67", "r72", "r133", "r205" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r67", "r72", "r133", "r205", "r282" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities - current", "verboseLabel": "Accrued expense" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r59", "r60", "r61", "r212", "r213", "r214", "r241" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r8", "r54", "r101", "r103", "r107", "r115", "r143", "r144", "r145", "r147", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r225", "r229", "r256", "r278", "r280", "r328", "r338" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r17", "r54", "r115", "r143", "r144", "r145", "r147", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r225", "r229", "r256", "r278", "r280" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Marketable securities held in Trust Account", "positiveLabel": "Marketable securities held in Trust Account", "terseLabel": "Cash and Marketable Securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r7", "r280", "r352", "r353" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash held in the Trust Account", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r7", "r48" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash held in its operating account", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r43", "r48", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r43", "r257" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Federal Depository Insurance" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Non-Cash Investing and Financing Activities:", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r9", "r10", "r11", "r52", "r54", "r75", "r76", "r77", "r79", "r81", "r87", "r88", "r89", "r115", "r143", "r148", "r149", "r150", "r154", "r155", "r168", "r169", "r173", "r177", "r184", "r256", "r362" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation", "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r192", "r207" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares issuable per warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Number of warrants to purchase shares issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants issued" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r192", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r24", "r331", "r341" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Commitments and Contingencies (NOTE 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES." } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r129", "r130", "r131", "r140", "r354" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsShares": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.", "label": "Common Stock Dividends, Shares", "terseLabel": "Share dividend" } } }, "localname": "CommonStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r59", "r60", "r241" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, shares authorized", "verboseLabel": "Common shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued", "verboseLabel": "Common shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r184" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r280" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stocks, $0.0001 par value; 100,000,000 shares authorized; 5,019,363 issued and outstanding (excluding 18,263,000 shares subject to possible redemption) at June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r93", "r337" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r156", "r160", "r161", "r265", "r267", "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r26", "r27", "r28", "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative Liability, Measurement Input" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r57", "r233", "r234", "r235", "r236", "r238" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r19", "r55", "r146", "r148", "r149", "r153", "r154", "r155", "r273" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r55", "r146", "r148", "r149", "r153", "r154", "r155", "r273", "r330", "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Amount due to related party" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r37", "r64", "r65", "r66", "r67", "r68", "r73", "r75", "r79", "r80", "r81", "r84", "r85", "r242", "r243", "r333", "r344" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic net income (loss) per common stock" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r37", "r64", "r65", "r66", "r67", "r68", "r75", "r79", "r80", "r81", "r84", "r85", "r242", "r243", "r333", "r344" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted net income (loss) per common stock" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r82", "r83" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r32", "r33", "r34", "r59", "r60", "r61", "r63", "r69", "r71", "r86", "r116", "r184", "r191", "r212", "r213", "r214", "r222", "r223", "r241", "r258", "r259", "r260", "r261", "r262", "r263", "r269", "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r46", "r162" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r244", "r245", "r251" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of quantitative information regarding Level 3 fair value measurements inputs" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Company's assets that are measured at fair value on a recurring basis", "terseLabel": "Schedule of company's assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r158", "r160", "r161", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r203", "r245", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r244", "r245", "r247", "r248", "r252" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r158", "r195", "r196", "r201", "r203", "r245", "r287" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r158", "r160", "r161", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r203", "r245", "r289" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r249", "r251" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r249", "r251" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of change in the fair value of the warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r158", "r160", "r161", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r203", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r250", "r252" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r110", "r111", "r112", "r113", "r114", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r159", "r182", "r239", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r362", "r363", "r364", "r365", "r366", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r31", "r215", "r216", "r218", "r219", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r45" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r45" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesPayableCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.", "label": "Increase (Decrease) in Notes Payable, Current", "terseLabel": "Promissory note-interest" } } }, "localname": "IncreaseDecreaseInNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r45" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other Receivable" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r35", "r100", "r264", "r266", "r334" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r21", "r54", "r104", "r115", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r226", "r229", "r230", "r256", "r278", "r279" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r15", "r54", "r115", "r256", "r280", "r329", "r340" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' DIFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r23", "r54", "r115", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r226", "r229", "r230", "r256", "r278", "r279", "r280" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r132", "r134", "r135", "r136", "r137", "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureCommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Exercise price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Expected term (years)" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Risk-free rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r90", "r99" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [TEXT BLOCK]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r43" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities:", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r43" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r43", "r44", "r47" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r29", "r30", "r34", "r36", "r47", "r54", "r62", "r64", "r65", "r66", "r67", "r70", "r71", "r78", "r101", "r102", "r105", "r106", "r108", "r115", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r243", "r256", "r332", "r343" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Income (Loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income:", "terseLabel": "Other income and expense:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Promissory notes" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r18", "r55", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Amount outstanding" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r55", "r273", "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Outstanding balance of related party note" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Formation and operating costs", "verboseLabel": "Formation and operating costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r101", "r102", "r105", "r106", "r108" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operation costs" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r38" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedLabel": "Non-operating expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivable" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-allotment option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r41" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10", "r168" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value, (per share)", "verboseLabel": "Preferred stock, par value, (per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred shares, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10", "r168" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred shares, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred shares, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitPreferredStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r280" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r16", "r126", "r127" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expense" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from issuance initial public offering", "terseLabel": "Proceeds from issuance initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r39" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issue of founder shares" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.", "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock", "terseLabel": "Gross Proceeds" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r39" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of private placement", "verboseLabel": "Aggregate purchase price" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r40" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "verboseLabel": "Proceeds from promissory note" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from promissory note - related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r29", "r30", "r34", "r42", "r54", "r62", "r70", "r71", "r101", "r102", "r105", "r106", "r108", "r115", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r224", "r227", "r228", "r231", "r232", "r243", "r256", "r335" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "terseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r202", "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r202", "r272", "r273", "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r272" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "verboseLabel": "Expenses incurred and paid" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r202", "r272", "r275", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r270", "r271", "r273", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r12", "r191", "r280", "r339", "r350", "r351" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r59", "r60", "r61", "r63", "r69", "r71", "r116", "r212", "r213", "r214", "r222", "r223", "r241", "r347", "r349" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Reconciliation basic and diluted net income per common stock" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r274", "r275" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r9", "r10", "r11", "r52", "r87", "r88", "r164", "r166", "r167", "r168", "r169", "r170", "r171", "r173", "r177", "r182", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Purchase price, per unit", "terseLabel": "Purchase price, per unit", "verboseLabel": "IPO price per Unit" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsExtensionLoanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "auth_ref": [ "r163" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "terseLabel": "Warrant Liability" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r9", "r10", "r11", "r52", "r54", "r75", "r76", "r77", "r79", "r81", "r87", "r88", "r89", "r115", "r143", "r148", "r149", "r150", "r154", "r155", "r168", "r169", "r173", "r177", "r184", "r256", "r362" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/DocumentDocumentAndEntityInformation", "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r25", "r32", "r33", "r34", "r59", "r60", "r61", "r63", "r69", "r71", "r86", "r116", "r184", "r191", "r212", "r213", "r214", "r222", "r223", "r241", "r258", "r259", "r260", "r261", "r262", "r263", "r269", "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Statements of Changes in Stockholders' Deficit" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r59", "r60", "r61", "r86", "r315" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r11", "r184", "r191" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock to Sponsor (in shares)", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited", "terseLabel": "Forfeiture of founder shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r11", "r184", "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock to Sponsor", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r211" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited", "terseLabel": "Forfeiture of founder shares" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r13", "r14", "r54", "r109", "r115", "r256", "r280" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets", "http://www.gacqu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r53", "r169", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r183", "r191", "r193", "r240" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r281", "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetails", "http://www.gacqu.com/role/DisclosureInitialPublicOfferingDetails", "http://www.gacqu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Re-measurement of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r143", "r148", "r149", "r150", "r154", "r155" ], "calculation": { "http://www.gacqu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Common stock subject to possible redemption", "verboseLabel": "Common stock subject to possible redemption, 18,263,000 shares, $0.0001 par value, at redemption value of $10.15 and $10.05 per share on June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernCommonStockIssuedToPublicReflectedOnBalanceSheetDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "verboseLabel": "Net income (loss) allocable to common stock subject to possible redemption" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r6", "r165" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Redemption par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r6", "r165" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Redemption value per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding", "verboseLabel": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureStockholdersEquityDeficitCommonStockSharesDetails", "http://www.gacqu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r6", "r165" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "terseLabel": "Summary of common Stock issued to the public reflected on the balance sheet" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAndGoingConcernTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r110", "r111", "r112", "r113", "r114", "r159", "r182", "r239", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r362", "r363", "r364", "r365", "r366", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r56", "r195", "r203", "r336" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "U.S. Treasury Securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r217" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r91", "r92", "r94", "r95", "r96", "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants." } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public Warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureWarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r74", "r81" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding, diluted", "verboseLabel": "Weighted average number of common stock, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r73", "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding, basic", "verboseLabel": "Weighted average number of common stock, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gacqu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesReconciliationBasicAndDilutedNetIncomePerCommonStockDetails", "http://www.gacqu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r277": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r357": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r358": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r359": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r360": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r361": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r362": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r363": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r364": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r365": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r366": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r367": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r368": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r369": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r370": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" } }, "version": "2.1" } ZIP 56 0001410578-22-002627-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-22-002627-xbrl.zip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end